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SYNTHESIS OF BORONIC ACID BASED SENSORS FOR GLUCOSE AND SIALIC ACID 
AND 
 SYNTHESIS OF NOVEL AND SELECTIVE PDE4 ENZYME INHIBITORS 
by 
GURPREET KAUR 
Under the Direction of Binghe Wang 
ABSTRACT 
 The boronic acid functional group is known to bind compounds with the diol group 
tightly and reversibly in aqueous environment and has been used as a recognition moiety for the 
design of carbohydrate sensors. The first chapter of the dissertation studies the synthesis and 
substitution effect on the affinity and selectivity of a known boronic acid-based glucose sensor.  
In such a sensor design effort, the availability of a signaling event, whether it is fluorescence or 
UV, is crucial.  The second chapter studies the detailed mechanism on how a well-known 
fluorescent boronic acid compound changes fluorescent properties upon binding.  A new 
mechanism has been established which corrected a decade old mistake.  In the third chapter, a 
series of boronic acid-based sensors were designed and synthesized for sialic acid, which is part 
of tetrasaccharide found on many cell surface carbohydrates. Such sialic acid sensors could be 
very useful for the development of new type of anti-influenza therapy.  The fourth is on the 
design and synthesis novel and selective inhibitors for phosphodiesterase 4 (PDE4), which are 
potential anti-asthma agents. 
INDEX WORDS: Boronic acid, PDE4, enzyme inhibitors, sialic acid sensors, glucose 
sensors, fluorescence  
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Chapter 1. Substituent effect on anthracene-based bisboronic acid 
glucose sensors 
 
Abstract: Anthracene-based boronic acid has been studied as potential sensors for 
glucose detection. Aimed at understanding the substituent effect, various functional 
groups were introduced, such as the cyano, nitro, and fluoro group on the boronic acid 
moiety of the glucose sensor.  Fluorescent binding studies indicated that the cyano-
substituted sensor has the highest affinity (Keq 2540 M-1) for glucose, but the lowest 
selectivity (3-fold over fructose); the fluoro-substituted compound shows the lowest 
affinity (630 M-1) and a modest selectivity (15-fold over fructose); and the unsubstituted 
one shows the highest selectivity over fructose (43-fold) and a modest affinity (1472 M-
1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
B
OH
HO B
OH
OH
1.1. Introduction 
 Carbohydrates are considered critical to various biological processes.1-5 The most 
prominent among them is glucose which is a critical energy supplier to cells, and its 
elevated concentration is the primary symptom of diabetes.6 Sensors for the biologically 
important carbohydrates have the potential to be used as diagnostics, new imaging agents, 
as well as therapeutics.7-9  Generally, selective sensors consists of three components: a) 
proper functional groups that afford strong intermolecular interactions (boronic acid), b) a 
‘reporter’ event/moiety (stars) that allows the binding event to be recognized, and c) the 
appropriate three-dimensional scaffold that allow for necessary complementarily in terms 
of size, shape, and functional group orientation (bridge) as shown in Figure 1.1. There is 
especially strong interest in developing boronic acid-based sensors10-16 because of the 
ability of the boronic acid group to form reversible and tight complexes with diol-
containing compounds.10, 13, 14, 17-25 Boronic acids have been used to develop fluorescent 
sensors,11, 13, 14, 21, 22, 26-28 color sensors,8, 11-13, 15, 16, 26, 29-36 sensors for cell recognition 
based on surface carbohydrate biomarkers,22 carbohydrate transporters,37-42 and 
chromatographic stationary materials.43-48  
 
 
 
 
Figure 1.1.  Three components of a "selective" sensor 
 3
1.1.1. Interaction between boronic acid and carbohydrate containing diols 
 Boronic acids covalently react with 1,2 or 1,3 diols to form reversible five- or six- 
membered cyclic esters in aqueous media. The cis diols of saccharides normally form 
stronger cyclic esters than the trans or acyclic diols.  Boronic acids are Lewis acids and 
can react with water to form the neutral trigonal form (1) to the anionic tetrahedral form 
(2) (Scheme 1). The same is true for the diol – boronic complex or the boronic ester (3).   
B(OH)2 B
HO OH
B
O
O
R1
R2 B
O
O
R1
R2HO
H2O H+
K a-acid
R1 R2
OHHO
Keq-trig
K a-ester
R1 R2
OHHO
2 H2O
Keq-tet
2 H2O
OH
(1) (2)
(3) (4)
H2O H+
 
Scheme 1.1. Binding process between phenylboronic acid and a diol 
 
1.1.2. Design of fluorescent boronic acid sensor 
 As mentioned above, a selective sensor requires proper functional groups that afford 
strong intermolecular interactions and a ‘reporter’ event/moiety that allows the binding 
 4
event to be recognized. The boronic acid moiety fulfills the requirement of strong 
intermolecular interaction needed for the sensor design. It is known that the monoboronic 
acids have certain intrinsic preference for various carbohydrates, the design of selective 
sensors for a particular sugar often relies on the introduction of additional functional 
group interactions, such as a second boronic acid unit, with a proper scaffold to afford 
selectivity.22 Such an approach has been successfully used in various examples.10, 11, 15, 32, 
49  Modulation of the affinity of a monoboronic acid for diols can be achieved through the 
introduction of various substituents on an arylboronic acid.  Generally speaking, 
arylboronic acids with lower pKa values tend to have higher affinities for diols, although 
one also needs to consider the pH of the solution and other factors.19 For example, 2-
fluoro-5-nitrophenylboronic acid has a pKa of about 6.0, which is 2.8 pKa units lower 
than that of phenylboronic acid.  Consequently, the binding constant between glucose and 
2-fluoro-5-nitrophenylboronic acid at physiological pH is about 10-fold higher than that 
of phenylboronic acid.19  A fluorophore fulfills the signaling event for the binding 
process of sensor. A fluorophore that can change fluorescence upon binding to a 
saccharide is an ideal for fluorescent sensor design. One way to design a fluorescent 
sensor is through the modulation of an excited state photoelectron transfer (PET) process 
that is responsible for the quenching of fluorescence.  
  The first fluorescence PET sensors for saccharides, the anthrylboronic acids (5 and 
6), showed significant fluorescence intensity changes upon binding with saccharide.13 
The fluorescence intensity change was due to the change in the hybridization state of the 
ester, which has lower pKa than the boronic acid (pKa about 8.8).  Specifically, the 
 5
boronic acid should exist mostly in the neutral trigonal state at the physiological pH and 
at such a state PET to the open shell of the boron can happen in the excited state leading 
to fluorescence quenching. However, upon ester formation, the boron functionality would 
exist in the anionic tetrahedral because of a decreased pKa and such a hybridization 
change abolishes the excited PET and therefore removes fluorescence quenching 
mechanism.  
B(OH)2
B(OH)2
5 6  
Figure 1.2. First fluorescence PET sensor developed 
 
  A second PET system was developed by Shinkai, where the amino group was 
positioned in a 1,5- relationship with the boronic acid. Such an arrangement promoted 
dative B-N bond formation.50 It was proposed for the anthracene system that the 
anthracene fluorescence can be quenched by the lone pair electrons of the amino group 
through excited state photoelectron transfer (PET).  It was further proposed that the B-N 
bond strengthens upon sugar binding, which “ties up” the lone pair electrons, abolishes 
the PET, and results in a fluorescence intensity increase. Although the mechanism 
proposed has proven to be incorrect (this will be discussed in detail in Chapter 2), indeed, 
upon sugar binding, 7 (Scheme 1.2) shows much higher fluorescent intensity.  The 
positioning of an amino group also lowers the pKa of the boronic acid, and increases its 
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binding affinity for diols.  Therefore, 7 showed much higher binding affinity to glucose 
and fructose compared with phenyl boronic acid.  Shinkai et al also developed a similar 
anthracene system with bisboronic acid unit (9).10 Compound 9 was selective for glucose 
over fructose. 
(HO)2B
N
hv
hv'
OHHO
R2R1
.. N
B
O
O
R2
R1
hv hv
(8)
Boronic acid
Weakly fluorescent
Boronate ester
Strongly fluorescent
(7)
OH
H
 
Scheme 1.2. Mechanism of an anthracene-based photoinduced electron transfer system 
 
N
(HO)2B
N
(HO)2B
9  
Figure 1.3. First bisboronic acid sensor developed by Shinkai 
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  Our group has designed a highly selective anthracene-based boronic acid sensor for 
glucose (10a, Figure 1.4).22 The sensor design used the Shinkai fluorescent reporter10 
which showed an increase in fluorescence intensity upon binding with a diol due to 
protonation of the amine nitrogen upon binding, the details of which will be discussed in 
Chapter 2.51 Compound 10a showed about 43-fold selectivity for glucose over fructose 
and 49-fold selectivity over galactose.   
 
NN
N
O
N
B(OH)2 (OH)2B
O
N B(OH)2
10a
10b
 
Figure 1.4.   Dianthraceneboronic acid (10a) and anthracenemonoboronic acid (10b) 
 
1.2. Project Objective 
In this study, we are interested in studying the effect of electron withdrawing 
groups on the binding affinity between the bisboronic acid and various saccharides. We 
designed and synthesized analogs of 10a and 10b with different electron-withdrawing 
 8
substitutents on the arylboronic acid portion of the bisboronic acid sensor aimed at 
achieving a better understanding of the substituents effect.  Specifically, there are two 
questions we wish to answer: (1) will the affinity-enhancing effect of electron 
withdrawing groups such as fluoro, nitro, and cyano substituents be translated into 
enhanced affinity of the bisboronic acid sensors for saccharide and (2) how will such 
electron-withdrawing groups affect the selectivity of the parent boronic acid sensors 10a 
and 10b. With that in mind three analogs of 10a22 and 10b10 with the cyano, nitro, and 
fluoro functional groups para position to the boronic acid were synthesized.  Their 
binding constants with various sugars were determined. 
1.3. Synthesis 
Well established routes were used to synthesis the building blocks and final 
bisboronic acids compounds.22, 36, 52 Figure 1.5 shows the target anthracene based 
bisboronic and monoboronic acids compounds that were synthesized.  
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NN
N
O
N
B(OH)2 (OH)2B
O
X X
N B(OH)2
X
 X = 25 = CN
       26 = NO2
       27 = F
 X = 29 = CN
        30 = NO2
        31 = F  
Figure 1.5.  Synthesized target bisboronic and monoboronic acids compounds 
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1.3.1. Synthesis route to the common building block, bisanthracene amide     
O
O
O
O
CHO
OH OH
NH
  Me3SI/NaH/DMSO LiBr/CH3CN
1) MeNH2/THF-MeOH
2) NaBH4
OH
N Boc
(Boc)2O/MeOH/TEA
92%
94% 95%
94%
N Boc
O H
Py.SO3/TEA/DMSO
99%
1) MeNH2/THF-MeOH
2) NaBH4
N Boc
NH
74%
O
HO
O
OH
N
N
O O
N
Boc NBoc
EDCI/ HOBT/ DMAP/DCM
59%
12
13 14
15 16
17 18
11
 
 
Scheme 1.3. Synthesis of intermediate Boc-protected diamides 18 
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 The synthesis of intermediate 18 took seven steps starting from the commercially 
available anthraquinone (11). 11 was first reacted with the trimethyl sulfonium ylide in 
dimethyl sulfoxide (DMSO) to give bis(epoxide), which then underwent rearrangement 
in the presence of lithium bromide in refluxing acetonitrile to give hydroxyaldehyde (13) 
in 94% yield.52  Reductive amination of hydroxyaldehyde with methyl amine in 
MeOH/THF and NaBH4 gave secondary amine (14) in 95% yield. The amine was 
protected with di-tert-butyldicarbonate in methanol in the presence of triethyl amine 
(TEA) to give 15 in 94 % yield. The hydroxyamine (15) was oxidized with pyridine 
sulfur trioxide complex in DMSO to give aldehyde (16) in quantitative yield. The 
resulting aldehyde underwent reductive amination to give amine (17) in 74% yield. The 
coupling reaction between amine (17) and the acid linker in the presence of 1-(2-
diemthyl-amino propyl)-3-ethylcarbodiimide hydrochloride (EDCI) gave the intermediate 
18 in 59 % yield.             
 
1.3.2. Synthesis of para substituted arylboronic esters  
 
 To study the effect of electron withdrawing groups on the binding affinity of the 
boronic acid for the saccharide, para substituted arylboronic acids were needed. For the 
study, three para substituted arylboronic acids were synthesized with cyano, nitro, and 
fluoro as electron withdrawing groups. They were then introduced to the intermediate 18 
to give the final bisboronic acids. Here only the syntheses of fluoro substituted 
arylboronic acid I prepared is reported (Scheme 1.4). The other two substituted aryl 
boronic acids (19, 20) were synthesized by Mr. Haibo Li using similar procedures.  
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Br
F
B
O
O
F
B
O
O
Br
F
B
OH
F
1) n-BuLi/THF,B(OiPr)3
2) HCl, H2O
HO
HO
Toulene, 125 o C
NBS/AIBN/Toulene
21 22
23 24
OH
   
Scheme 1.4. Synthesis of 4-fluoro-2- phenylboronic acid (24) 
 
Commercially available bromo-2-methyl-4-fluoro-benzene (21) was 
transmetalated with n-butyl lithium and then quenched with trisopropyl borate to give 
protected boronic acid which was cleaved during acidic work up to give free boronic acid 
(22). Free boronic acid was then protected with neopentyl glycol at 115 °C for the ease of 
deprotection at the end of the synthesis.  Bromination of 23 in presence of NBS and 
AIBN yielded 24 in 68% yield.  
The above method for the synthesis of neopentyl protected boronic acid (24) took 
three steps whereas a recently developed palladium catalyzed borylation method can be 
done in two steps for the same compound (24).  Also, the palladium-catalyzed method 
can be used for the borylation of substrates that contain functional groups such as cyano, 
nitro, amino, hydroxyl, which may not be compatible with organometallic agents such as 
n-butyllithium. A separate study was conducted to examine the new bis(neopentyl 
glycolato)diboron borylating agent for the palladium catalyzed reaction with substrates 
substituted with various functional groups (see section 1.6).     
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1.3.3. Synthesis of bisboronic acid and monoboronic acid compounds 
N
N
O O
N
Boc NBoc NN
N
O
N
O
B(OH)2
X X
(HO)2B
X
Br
B O
O
X = 19 = CN
       20 = NO2
       24 = F
18 25 = CN26 = NO2
27 = F
a, b, and c
 
Scheme 1.5.  (a) TFA, DCM; (b) 19, 20, 24, K2CO3, KI, CH3CN; (c) 25 and 26: DCM,          
10%NaHCO3, H2O; 27: acetone: H2O (4:1), 1N HCl 
 
 
  Bisboronic acid sensors, compound (25-27) were prepared through alkylation of 
intermediate 18 with substituted arylboronic acids. 18 was deprotected using 
trifluoroacetic acid (Scheme 1.5) and the free amino group was then reacted with 19, 20, 
and 24, respectively, in the presence of K2CO3 in acetonitrile at room temperature to give 
the corresponding boronate esters of 25-26. Hydrolysis of the protected boronic acids 
under basic conditions in the presence of NaHCO3 gave the free boronic acids 25 and 26; 
whereas free boronic acid 27 was obtained under acidic condition in the presence of 
HCl.22 
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       20 = NO2
       24 = F
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28
 
Scheme 1.6.  (a) 19,20,24, K2CO3, KI, CH3CN; (b) 29 and 30: DCM, 10%NaHCO3, 
H2O; 31: acetone: H2O (4:1), 1N HCl 
 
 
 
 For the synthesis of the monoboronic acids, commercially available anthracen-9-
ylmethyl-methylamine (28) was reacted with 19, 20, and 24, respectively, in the presence 
of K2CO3 in acetonitrile at room temperature to give the corresponding boronate esters 
(Scheme 1.6). Hydrolysis of the protected boronic acids was done under the same 
conditions as mentioned above to obtain free boronic acids 29-31.22 
1.4. Binding Studies 
  The bisboronic acid and monoboronic acid compounds mentioned above were 
expected to show increase in fluorescence upon sugar binding.  Furthermore, we were 
interested in seeing whether substitutions would change the binding affinity of the 
bisboronic acid sensors for diols parallel to that of the monoboronic acid unit.  Therefore, 
fluorescence experiments were conducted to determine the appropriate binding constants 
of 25-27 and 29-31 for various sugars. Since the anthracene-based compounds are fairly 
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lipophilic, a 1:1 mixture of methanol and phosphate buffer (pH 7.4) was used as the 
solvent with a sensor concentration of about 1 × 10-6 M. The sugars studied include 
glucose, fructose, and galactose.  As expected, upon sugar addition, all three substituted 
glucose sensor analogs (25-27) showed dramatically increased fluorescence intensity. 
Figure 1.6 shows two typical sets of fluorescent spectral changes upon sugar addition 
using compound 25-27 as examples. It has been proposed in literature that the increase in 
fluorescence intensity for such anthracene based boronic acids upon addition of a 
saccharide was due to increased B-N bond strength upon sugar binding, which in turn 
resulted in reduced fluorescence quenching by photoinduced electron transfer (PET).10 
Whereas we have established a different mechanism, the hydrolysis mechanism, for the 
increase in the fluorescence intensity upon addition of a sugar. The hydrolysis 
mechanism will be discussed in detail in Chapter 2. One would expect these new analogs 
to have a similar mechanism in inducing the fluorescent changes upon sugar binding, 
although this was not specifically studied.    
 
With the four analogs of dianthraceneboronic acid in hand, the cyano-substituted 
compound 25 showed the highest change in fluorescence intensity with a 10-fold increase 
upon glucose addition.  It also showed the highest binding affinity with an apparent 
binding constant (Ka) of 2540 M-1 for glucose (Table 1.1). It is interesting to see that the 
nitro-substituted compound (26) showed the lowest fluorescent intensity changes (a 
maximum of 2 fold), while having the second highest affinity for glucose (1808 M-1).  
The fluoro-substituted analog (27) showed only 4-fold fluorescent intensity change with a 
binding constant (630 M-1) that is even smaller than that of the parent compound (10a, 
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1472 M-1).  The binding of these bisboronic acids was compared with that of the 
corresponding monoboronic acid analogs (29-31, Table 1.2).  It is interesting to note that 
the cyanophenylboronic acid compound (25) also showed much higher affinity than 
either the nitro (26) or fluoro (27) substituted ones.  Therefore, the results of the 
bisboronic acids parallel that of the monoboronic acids in this case.              
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Figure 1.6.  a) Fluorescence spectra of 25 (1.0 × 10-6 M) with D-glucose (0 mM-10 mM); 
b) Fluorescence spectra of 26 (1.0 × 10-6 M) with D-glucose (0 mM-20 mM) at 25 oC in 
50% MeOH/0.1 M aqueous phosphate buffer at pH 7.4: λex = 370 nm. 
The comparison between the nitro and fluoro-substituted compounds did not yield 
the same conclusions.  In the monoboronic acid series, the nitro and fluoro-substituted 
boronic acids (30 and 31) had similar affinities for both fructose and glucose.  On the 
other hand, in the bisboronic acid series, the nitro-substituted compound (26) showed a 
much higher affinity than the fluoro-substituted one (27).  It is also worth noting that the 
fluoro-substituted bisboronic acid has an even lower affinity than that of the unsubstituted 
control (10a). Such results were somewhat unexpected because fluoro-substitution is 
electron-withdrawing.  Furthermore, the size of the fluorine atom is small and one would 
not expect much perturbation of the conformation of the bisboronic acid compound by 
the fluorine atom.  Consequently, one would expect 27 to have a higher affinity for 
glucose than does 10a.   
0mM
20m
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The results of the selectivity studies were also somewhat surprising.  Sensor 25, 
although having the highest affinity for glucose, showed the lowest selectivity with a 3-
fold preference for glucose over fructose in terms of the binding constants.   This is in 
direct contrast to the 43-fold selectivity of 10a for the same pair of sugars.22  Compounds 
26 and 27 were somewhere in between.  In comparison with the monoboronic acids, it 
seems that the cyano-substituted one has a low selectivity problem too, only in this case it 
was the selectivity for fructose.  Such results could mean that the cyano-substituted 
boronic acids have a lower propensity to discriminate among different sugars.  However, 
the underlying reason for this is not clear.  
 
Table 1.1.  Binding Constant (Ka) for compounds 25-27 and 10a with different    
saccharides 
 
Compound Ka (M-1) 
glucose 
 
Ka (M-1)  
    fructose 
 
Ka (M-1)   
galactose 
 
Selectivity 
Ka glucose/Ka 
fructose 
Fluorescence 
intensity 
changes for 
glucose 
25 2540 ± 90.1 968 ± 126.6 271 ± 37.5 3 10-fold 
increase 
26 1808 ± 130.6 198 ± 32.8 132 ± 60.5 9 2-fold 
increase 
27 630 ± 48.6 42 ± 7.2 46 ± 6.6 15 4-fold 
increase 
10a 1472 34 30 43 7-fold 
increase 
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Table 1.2.  Binding Constant (Ka) for monoboronic acids 29-31 and 10b with different 
saccharides 
 
Compound Ka (M-1) 
fructose 
 
Ka (M-1) 
glucose 
 
Selectivity 
Ka fructose/Ka 
glucose 
Fluorescence 
intensity changes 
for fructose 
29 1350 ± 68.4 101 ± 5.2 13 2.3-fold increase 
30 714 ± 51.3 40 ± 4.0  18 2-fold increase 
31 650 ± 29.2  26 ± 8.3  25 2.3-fold increase 
10b 940 50  18 2- fold increase 
 
 
Overall, the results indicate that the substituent effect on monoboronic acids can 
only be partially translated into the same kind effect when used for the preparation of 
bisboronic acid compounds.  Other factors such as conformational changes may also need 
to be considered in designing analogs aimed at optimizing the affinity and selectivity of 
the interested sensors. 
There is one additional point that is worth discussing, i.e., why the substituent 
electron-withdrawing ability did not correlate with the apparent binding constants of the 
monoboronic acids (10b, and 29-31) (Tables 1 and 2).  As has been reported previously, 
the apparent binding constant of a particularly boronic acid can be affected by several 
factors including (1) the pKa values of the boronic acid and the diol, (2) the optimal pH 
for a particular complexation reaction, (3) steric factors, (4) the concentration and nature 
of the buffer, (5) whether trivalent interaction is involved, and (6) other idiosyncratic 
factors that have not been identified.19  Among these factors, a shift of the optimal pH 
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away from 7.4 to a lower pH is most likely the reason for the diminished intrinsic affinity 
of 29 and 30 for diols at pH 7.4 compared with the un-substituted one (10b).  Similar 
examples have been reported before, especially with boronic acids that have a very low 
pKa value.19  
1.5. Conclusions 
Three new fluorescent anthracene-based bisboronic sensors (25-27) and three 
monoboronic fluorescent sensors (29-31) were synthesized. Both cyano- (25) and nitro-
substituted (26) sensors had higher apparent binding constant for glucose (K 2540 M-1 
and 1808 M-1 respectively) than the parent sensor (10a) (1472 M-1). Whereas fluoro-
substituted bisfluoroboronic acid (27) had a lower apparent binding constant (K 630M-1) 
but it has the most appropriate affinity and selectivity for glucose sensing under 
physiological conditions. The selectivity between glucose and fructose did diminish for 
all the new sensors (25-27) compared to 10a.  The monoboronic acid series sensors (29-
31) also showed similar trend in the affinity for saccharides compared with their 
bisboronic acid analogs. Again, monofluoroboronic acid sensor (31) had the lowest 
binding constant but showed a greater selectivity (25 fold) than 29 for fructose over 
glucose.  Overall, the introduction of an electron-withdrawing group does not always 
directly translate into enhanced affinity, and the affinity of the bisboronic sensors only 
partially tracks that of the monoboronic building blocks.  The effect of the electron-
withdrawing group in the selectivity of the bisboronic acid sensors is hard to predict.    
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1.6. Palladium catalyzed synthesis of sterically hindered arylboronic esters 
1.6.1. Contributions 
The goal of this project was to study the new borylating agent (bis(neopentyl 
glycolato)diboron) for the palladium catalyzed synthesis of hindered arylboronic acid. In 
this methodology study 12 ortho substituted boronic esters were synthesized.  Dr. Hao 
Fang synthesized 7 boronic esters and I synthesized 5 boronic esters.  Detailed synthesis 
of boronic esters that I performed will be given with full characterization.   
1.6.2. Introduction 
Generally, two methods are used to synthesize arylboronic acid or ester compounds. 
One is the transmetalation between an arylmetal and a boron halide or alkoxide;53 the 
other is the recently developed PdCl2(dppf)-catalyzed borylation of aryl halides,54 
triflates55, 56 and diazonium57, 58with a tetra(alkoxy)diboron 54, 55, 57 or  dialkoxyborane 
reagent.56, 59  The palladium-catalyzed method can be used for the borylation of substrates 
that contain functional groups such as cyano, nitro, amino, hydroxyl, ester and carbonyl 
groups, which may not be compatible with organometallic agents such as n-butyllithium. 
Currently, bis(pinacolato)diboron (32) is the most widely used agent in palladium 
mediated borylation reactions due to its commercial availability and good stability in the 
presence of water and during chromatography.60 
In the synthesis of boronic esters, many problems were encountered when 
bis(pinacolato)diboron was used as the borylation agent. For example, complicated 
reaction mixtures were obtained in the preparation of ortho-methoxy-substituted 
phenylboronic acid, which led to low yields (about 20%).61 Similar results have also been 
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reported in the literature,54although a few exceptions were reported when aryltriflates 
were used instead of arylhalides.55 Baudoin and coworkers utilized pinacolborane 
(Me4C2O2)BH to synthesize phenylpinacol boronic esters from ortho-substitued aryl 
bromides and found the best catalyst being Pd(OAc)2 in the presence of 2-(dicyclohexyl 
phosphino)biphenyl which is a sterically hindered phosphine ligand,59 although the yields 
were still poor when functional groups such as nitro (20%), acetyl (0%), and Boc 
protected amino group (40%) were present. Later Miyaura’s group reported that 
Pd(dba)2/PCy3 could be used to carry out borylation of some ortho-substituted 
chloroarenes (nitro and methoxy) by using bis(pinacolato)diboron (70% yield based on 
GC after 48 hours of reaction).62 Most recently, a new N-heterocyclic carbene-palladium 
catalyst was used to borylate ortho-methoxy substituted aryldiazonium with good yields 
using bis(pinacolato)diboron.58 
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Figure 1.7.   Bisborylating agents (a) bis(pinacolato)diboron (b)                                         
bis(neopentylglycolato)diboron 
 
So far, research in this area has been focused on examining the effect of different 
leaving groups or designing or experimenting new palladium catalysts. We envisioned 
that some of the problems might be overcome by manipulating the steric bulkiness of the 
borylation agent. In our very first example, we examined the borylation of 2-methoxy-5-
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nitrophenylbromide using the new commercially available bis(neopentyl 
glycolato)diboron 33 in the presence of PdCl2(dppf) and observed much improved yield 
compared with the reaction using bis(pinacolato)diboron as the borylation agent (72% vs. 
20%) under similar conditions (Scheme 1.7.). Such results suggested that the steric 
bulkiness of the tetra(alkoxy)diboron agent may play an important role in the borylation 
of other ortho-substitutent arylhalide (bromide in this case) and a less hindered 
bis(neopentyl glycolato)diboron might be used to overcome the side reaction problems 
associated with the use of sterically bulky bis(pinacolato)diboron. 
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Scheme 1.7. General synthesis route to neopentyl protected boronic ester 
 
 
1.6.3. Synthesis of ortho-substituted aryl boronic esters 
 
In order to understand the scope of the effect of the steric bulkiness of the borylation 
agent, we were interested in examining the borylation of a series ortho-substituted 
arylhalides.  As a first step, we optimized the reaction conditions with respect to the 
solvent and base used.  As expected and has been observed with reactions using the 
bis(pinacolato)diboron borylation agent, DMSO was the best solvent and KOAc was the  
best base. Toluene and dioxane exhibited low reaction rate with more debromo product. 
The reaction did not work when using triethylamine as base. 
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The borylation of 12 additional arylhalides were studied using this method (entry 2-
13, Table 1.3).  In most cases, the reaction was completed within 4 hours. Good (65%) to 
excellent (90%) yields were obtained in most cases except with 8-quinoline analog (entry 
9, 35%), 2-bromophenol (entry 11, 5%), and 2-bromobenzaldehyde (entry 13, 7%). 
Unexpectedly, borylation of Boc protected 2-bromoaniline (entry 3) gave the deprotected 
aniline neopentyl glycolato boronate. The mechanism through which the Boc group was 
cleaved is unclear. Comparing with literature and our own research results, the yields 
were much better than the reactions using bis(pinacolato)diboron or pinacolborane as the 
borylating agent. For example, ortho-bromonitrobenzene (entry 4) and 2-
bromomethylphenylketone (entry 8) gave yields in the range of 0-20% when 
pinacolborane was used as the borylating agent.59 Even when the corresponding 
iodoarene was used for the nitrobenzene analog, the yield was still low (44%).59 In 
contrast, the corresponding reactions using bis(neopentyl glycolato)diboron as the 
borylation agent gave over 68% isolated yields for both nitro (entry 4)  and acetyl 
substituent (entry 8). 
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        Table 1.3. Representative Reactions 
 
 
Entry 1 Product 3 Time (h) 3 (%)a 
 
 
1 Br
OCH3
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O
O
 
 
35b 
 
2 
 
69 
 
3 
Br
NHBoc
 
 
34c 
NH2
B
O
O
 
 
35b 
 
4 
 
65 
 
4 
Br
NO2
 
 
34d 
NO2
B
O
O
 
 
35d 
 
3 
 
68 
 
5 
Br
F
 
 
34e 
F
B
O
O
 
 
35e 
 
4 
 
(90) 
 
6 
CO2CH3
Br
 
 
34f 
CO2CH3
B
O
O
 
 
35f 
 
4 
 
80 
 
7 
Br
CN
 
 
34g 
CN
B
O
O
 
 
35g 
 
6 
 
73 
 
 
8 
Br
O
 
 
 
34h 
B
O
O
O
 
 
 
35h 
 
 
3 
 
    
70 
 
 
9 
N
Br
NHBoc
 
 
 
34i 
N
B(OH)2
NHBoc
 
 
 
35i 
 
 
12 
 
 
35 
 
10 
N
Br
N Boc
 
 
34j 
N
B(OH)2
N Boc
 
 
35j 
 
12 
 
85 
 
11 
Br
OH
 
 
34k 
B
OH
O
O
 
 
35k 
 
12 
 
5 
 
12 
I
OH
 
 
 
34l 
B
OH
O
O
 
 
35k 
 
8 
 
70 
 
13 
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7 
                           a isolated yield after flash chromatography. Yields in parentheses are GC yields. 
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On a somewhat different note, where steric hindrance may not necessarily be a 
factor, the borylation of quinoline bromide also benefited from using bis(neopentyl 
glycolato)diboron instead of bis(pinacolato)diboron as the borylation agent.  For 
example, in the borylation of 8-bromoquinoline derivatives (Entries 9 and 10), Suzuki 
coupling product was the major product when bis(pinacolato)diboron was used as a 
borylation agent in the presence of KOAc.63 However, when bis(neopentyl 
glycolato)diboron was used, Suzuki coupling product was not formed in the reaction 
mixture and the corresponding 8-quinoline boronic acid was easily obtained. 
It does need to be noted that entry 13 (with a formyl substituent) gave less than 10% 
yield of the desired product with the formation of 20% Suzuki coupling product and the 
recovery of 50% of the starting material. In addition, entry 11 (hydroxyl group) gave only 
5% yield of the desired product with over 85% of the starting material recovered, while 
the corresponding iodide (entry 12) gave a good yield (70%). It is not clear why the 
hydroxyl group (entry 11) and the formyl group (entry 13) presented special problems.  
In an effort to improve the yields for entries 11 and 13, we also examined whether 
different catalysts would be able to facilitate these two reactions. Previous work in the 
Baudoin59 and Miyaura groups62 indicates that a more reactive palladium catalyst may be 
able to improve yield of entry 11. Several air stable and more active palladium catalysts, 
such as [(t-Bu)2P(OH)]2PdCl2 (POPd), {[(t-Bu)2P(OH)][(t-Bu)2P(O-)]PdCl}2 (POPd1), 
and [(t-Bu)2P(OH)PdCl2]2 (POPd2), have been employed for cross-coupling reactions of 
aryl chloride,64-66 and also for borylation of 5-bromofluorescein diacetate.67 Therefore, 
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the new active palladium catalyst, POPd, was examined in the borylation of 2-
bromophenol and 2-bromobenzaldehyde. 
Different palladium catalysts and solvents were examined in order to search for a 
condition that would give a reasonable borylation yield from 2-bromophenol (Table 1.4). 
The results showed that the POPd facilitates the borylation reaction and works better than 
Pd(PPh3)4 and PdCl2(dppf) in DMSO (entries 1-3). When the temperature was raised to 
120 ºC, 40% of the desired borylation product was obtained, with the remaining portion 
being the un-reacted starting material (entry 4).  When the solvent was changed to 
toluene and dioxane, the debromo product (36) was the main product (entries 6 and 7).  
Therefore, it seems that for the borylation of 2-bromophenol using POPd in DMSO at 
120 ºC gives the best yield.  When applying the same conditions to the borylation of 2-
bromobenzaldehyde, the starting material completely disappeared with the formation of 
35% (isolated yield) of the desired borylation product and the remaining being the Suzuki 
coupling product 
Table 1.4.   Different Palladium Catalysts in the Borylation of 2-bromophenol and 2-
bromobenzaldehyde 
 
Br
X
X
B
O
O
O
B
O
B
O
O
33
Catalyst, KOAc
35
H
X
36k    X = -OH
m   X = -CHO k   X = -OHm  X = -CHO
k   X = -OH
m  X = -CHO
34
 
Entry Catalyst Solvent Heating method 
(temp. oC, time) 
Product ratio 
34k:35k:36ka 
1 Pd(PPh3)4 
(6%mol) 
DMSO 100, 12h 100:0:0 
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2 PdCl2(dppf)  
(6% mol) 
DMSO 100, 12h   93:7:0 
3 POPd (3% mol) DMSO   80, 12h  78:22:0 
4 POPd (3% mol) DMSO 120, 12h 60:40:0 
5 POPd (3% mol)       DMF   80, 12h 74:27:0 
6 POPd (3% mol) Toluene    80, 12h  0:27:73b 
7   POPd (3% mol) Dioxane    80, 12h  0:10:80b 
                  aDetermined by GC-MS 
                  bDetermined by 1H-NMR 
 
 
1.7. Conclusions 
  Palladium catalyzed borylation of arylbromide is a very convenient way for the 
preparation of arylboronic acids.  However commonly used borylation reagent, 
bis(pinacolato)diboron, gives low yields and side reactions for ortho-substituted 
bromoarenes, possibly due to the steric hinderance presented by the ortho substitutent. 
This problem can be overcome by using a less hindered borylation agent, bis(neopentyl 
glycolato)diboron, in most of cases. With the two cases (ortho substituent being a 
hydroxyl or a formyl group) that give low yields of the borylation product, the problem 
can be addressed by using a new and more active palladium catalyst, such as POPd. 
1.8. Experimental  
1.8.1. General Procedures 
 All air- and water sensitive reactions were performed under dry Nitrogen in oven 
dried glassware. Commercially available reagents were used without additional 
purification unless otherwise indicated. Dichloromethane was distilled from CaH2. THF 
was distilled from sodium and benzophenone.  
Analytical thin layer chromatography (TLC) was performed with Scientific 
Adsorbents plastic-baked TLC silica gel 60 F hard layer plates. TLC plates were 
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visualized with UV light (254 nm) or with 5% (w/v) solutions of phosphomolybidic acid 
in ethanol. Flash chromatography was performed with Scientific Adsorbents silica gel 
(flash 32-63 nm). 
Mass spectrometry (MS) analyses were performed by the Mass Spectrometry 
Laboratories of Georgia State University. 1H and 13C NMR spectra were recorded at 75 
MHz and 100 MHz. Chemical Shifts (δ) are given in ppm relative to TMS for 1H spectra 
and relative to residual solvent for 13C spectra.  
1.8.2. Fluorescence Binding Study Procedure 
Fluorescence measurents were used to determine the bidning between boronic 
acid (BA) and saccharide. Fluorescence polarization is a measure of rotatational 
relaxation time, so upon binding of a small molecule to a large molecule the fluorescene 
polarization of small molecule changes which in turn reflects the relaxation time of the 
large molecule. This effect indicates the binding event. The relationship between 
fluorescence intensity change and the equilibrium constant can be expressed using 
equation 1. At sufficiently low concentration where a plot of ∆If vs. concentration sugar 
complex is linear:        
        ∆If =  1+ K1 [Sugar]       Equation 1 
 
A plot of 1/∆ If vs 1/[Sugar] gives K1= intercept / slope 
 
   A Shimadzu RF-5301PC fluorometer was used for all the fluorescent studies. 
For a typical fluorescent measurement, a 2 mL of sensor stock solution in methanol (2.0 
× 10-6 M) was mixed with 2 mL of saccharide solution in 0.1 M of phosphate buffer (pH 
7.4) at various concentrations.  The apparent pH was checked with pH meter and 
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corrected if necessary. The mixture was allowed to mix for 20 min and fluorescence 
intensity was recorded.  Triplicate measurements were taken for each sugar. The 
correlation coefficients for all determinations in fitting the 1:1 model were over 0.98.   
1.8.3. General Procedure for the Synthesis of Arylboronates 
A mixture of palladium catalyst (0.03eq), potassium acetate (3eq), bis(neopentyl 
glycolato)diboron (1.2eq) and arylbromide was added to a flask in a glove box under 
anhydrous condition. After addition of anhydrous DMSO (8 mL/mmol), the mixture was 
stirred at 80 0C several hours checked by TLC. The reaction solution was cooled to room 
temperature and poured into ice-water. The mixture was extracted with ethyl acetate and 
the combined organic layers was washed with saturated brine, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by flash column chromatography to give 
the corresponding arylboronates. 
1, 10-Diexpoxide-anthracene (12). The preparation followed the literature procedure.52 
A stirred suspension of anthraquione (4.0 g, 1mmol) and sodium hydride (2.2 g, 2.5 
mmol) in ahydrous DMSO was added dropwise to a solution of trimethylsulfonium 
iodide (11.0 g, 2.5 mmol) in anhydrous DMSO at room temperature over a period of 30 
min and stirred for another 3h. The mixture was filtered and the filtrate was poured into 
350 ml ice water. The mixture was allowed to stand for 2h, and then the precipitate was 
washed with water and dried under vacuum at 45 o C overnight giving the diexpoxide in 
92 % yield with no further purification.  1HNMR (300 MHz, CDCl3) δ: 3.25 (4H, s), 7.38 
(8H, d, J = 1.2 Hz) ppm, was in agreement with the literature data.52 
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 10-Hydroxymethyl-anthracene-9-carbaldehyde (13).  Compound 12 (3.3 g, 1mmol) 
was added to stirred solution of lithium bromide (19.3 g, 5 mmol) in dry CH3CN, and the 
mixture was stirred at 60 o C in the dark for 16h and then was cooled to -40 o C in a dry 
ice-acetonitrile bath. The resulting product were collected by filtration, washed with 
water, and dried overnight under vacuum to give 13 in 94% yield.   1HNMR (300 MHz, 
CDCl3) δ: 5.67 (2H, s), 7.64 (4H, m), 8.54 (2H, d, J = 8.4 Hz), 8.87-8.89 (2H, q, J = 1.5, 
6 Hz), 11.47 (1H, s) ppm, was in agreement with the literature data.52 
10-Methylaminomethyl-anthracen-9-yl)-methnaol (14).  An aqeous solution of 
methylamine (40% wt, 25 mL) was added to the solution of compound 13 (0.48 g, 
1mmol) in MeOH (10 mL) and THF (5 mL) and stirred at room temperature for 16h. To 
the stirred mixture was added sodium borohydride (0.39 g, 5 mmol). The solution was 
stirred for another 30 min. After solvent evaporation, the resulting solid was dissolved in 
EtOAC (10 mL). The solution was washed with water (2 x 20 mL) and brine (20 mL), 
dried over MgSO4 and concentrated. The resulting crude product was purified with silica 
gel column with eluent of MeOH/CH2Cl2 to give compound 14 in 95 % yield.   1HNMR 
(300 MHz, CDCl3) δ: 2.68 (3H, s), 4.69 (2H, s), 5.67 (2H, s), 7.55 (4H, m), 8.40-8.46 
(4H, m) ppm, was in agreement with the literature data.36 
(10-Hydroxymethyl-anthracene-9-ylmethyl)-methyl-carbamic acid tert-butyl ester 
(15). Compound 9 (0.49 g, 1mol), di-tert-butyl dicarbonate (2.5 g, 2.5 mmol) and 
triethylamine (5 mL) were mixed in MeOH (30 mL), and the mixture was stirred at room 
temperature for 30 min. After removal of the solvent, the resulting residue was dissolved 
in DCM (10 mL). The solution was washed with water (3 x 10 mL), and saturated brine 
 32
(15 mL), dried over MgSO4 and concentrated. The resulting compound was dried under 
vacuum to give 15 in 94 % yield. 1HNMR (300 MHz, CDCl3) δ: 1.57 (13H, s), 2.48 (3H, 
s) 5.50 (2H, s), 5.70 (2H, s), 7.59-7.52 (4H, m), 8.50-8.42 (4H, m) ppm, was in 
agreement with the literature data.36 
(10-Formyl-anthracene-9-ylmethyl)-carbamic acid tert-butyl ester (16).  Compound 
15 (0.64 g, 1 mmol) was dissolved in the mixture of dry DMSO (10 mL) and 
triethylamine (15 mL). To the solution was added the solution of pyridine sulfur trioxide 
(1.76g, 6 mmol) dissolved in dry DMSO (5 mL) over period of 30 min, and then was 
poured into ice water (200 mL). The mixture was extracted with EtOAc (3 x 20 mL), 
dried over MgSO4 and concentrated.  The resulting solid gave 16 in 99 % yield. 1HNMR 
(300 MHz, CDCl3) δ: 1.56 (9H, s), 2.50 (3H, s), 5.56 (2H, s), 7.64-7.25 (4H, m), 8.53 
(2H, d, J = 8.4 Hz), 8.91 (2H, d, J = 9.6 Hz), 11.51 (1H, s) ppm, was in agreement with 
the literature data.36 
Methyl-(10-methylaminomethyl-anthracen-9-ylmethyl)-carbamic acid tert-butyl 
ester (17).  Compound 16 (0.61 g, 1 mmol) was dissolved in THF (10 mL) and MeOH 
(20 mL). To this solution was added an aqueous solution of methylamine (40%, wt, 20 
mL), and the resulting reaction mixture was then stirred at room temperature under N2 for 
12h. Sodium borohydride (0.33 g, 5 mmol) was added, and the reaction mixture was 
stirred for 30 min. The mixture was concentrated and dissolved in CH2Cl2. The solution 
was washed with water (2 x 10 mL) and brine (20 mL), dried over MgSO4 and 
concentrated. The resulting crude product was purified on silica column, eluting with 
CH2Cl2/MeOH (20/1), giving compound 17 in 74% yield.  1HNMR (300 MHz, CDCl3) δ: 
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1.56 (9H, s), 2.48 (3H, s), 2.70 (3H, s), 4.72 (2H, s), 5.51 (2H, s), 7.25-7.58 (4H, m), 
8.38-8.42 (4H, dd, J = 2.4, 1.2 Hz) ppm, was in agreement with the literature data.36 
Boc-protected diamides (18).  Compound 17 (0.73 g, 1 mmol), was added to a solution 
of (2-Carboxymethyl-phenyl)-acetic acid (0.19 g, 0.5 mmol), 1-(2-diemthyl-
aminopropyl)-3-ethylcarbodiimide hydrochloride (EDC. HCl, 0.77 g, 2 mmol), (HOBT, 
0.27g, 1 mmol), (DMAP, 49 mg, 0.2 mmol), TEA (200 µL) in dry CH2Cl2 (60 mL), and 
the mixture was stirred at room temperature at room temperature under N2 for 12h.  The 
solution was washed with 10% citric acid (10 mL), and water (2 x 20 mL), and was dried 
over MgSO4 and concentrated under vacuo. The residue was purified on silica gel 
column, eluting with Hexane/EtOAc (1/1) to give 18 in 54% yield.  1HNMR (300 MHz, 
CDCl3) δ: 1.59 (22H, s), 2.27 (6H, s), 2.36 (6H, s), 3.71 (4H, s), 5.46 (4H, s), 5.66 (4H, 
s), 7.27 (4H, s), 7.49 (8H, t, J = 8.1 Hz), 8.42 (8H, t, J = 7.2 Hz)  ppm, was in agreement 
with the literature data.36 
4-Fluoro-2-methyl-boronic acid (22).  Commercially available 1-bromo-4-fluoro-2-
methyl-benzene 21 (1.02 g, 1mmol) was dissolved in dry THF (15 ml) and treated with n-
BuLi (2M in pentane, 1.3 mmol) at -78 o C for 1 hour under N2.  Trisopropyl borate (1.62 
ml, 1.3 mmol) was added drop wise into the flask and reaction was mixed for overnight at 
room temperature.  The reaction was treated with 1N HCl (20 mL) for 1 hour and 
extracted with ethyl acetate (3 x 10 mL), and was dried over MgSO4 and concentrated 
under vacuo to give free boronic acid 17 in 75 % yield. 1HNMR (400 MHz, CDCl3) δ: 
2.42 (3H, d, J = 36.8 Hz), 6.81- 6.92 (2H, m), 7.25-7.45 (1H, t(t), J = 7.6 Hz ) ppm, was 
in agreement with the literature data.68 
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2-(4-Fluoro-2-methyl-phenyl)-5-methyl-[1,3,2] dioxaborinane (23).  Compound 22 
(0.64 g, 1 mmol) and neopentyl glycol (0.52 g, 1.2 mmol) were mixed in toluene and 
refluxed for 18 hours in a Dean-Stark setup. Reaction was cooled to room temperature 
and solvent was evaporated. Crude product was chromatographed on silica column using 
hexane-ethyl acetate as eluent to give 23 in 83%. 1HNMR (300 MHz, CDCl3) δ: 1.03 
(6H, s), 2.51 (3H, s), 3.76 (4H, s), 6.81(2H, m), 7.88 (1H, t, J = 6.9 Hz) ppm, was in 
agreement with the literature data.68 
2-(2-Bromomethyl-4-fluoro-phenyl)-5,5-dimethyl-[1,3,2]dioxaborinane (24).  
Compound 23 (0.66g, 1mmol) was brominated in the presence of NBS (0.58g, 1.1mmol) 
and catalytic amount of AIBN (10mg) and refluxed in benzene for 18 hours.  Crude 
product was chromatographed on silica column using hexane-ethyl acetate as eluent to 
give 24 in 68%.  1HNMR (300 MHz, CDCl3) δ: 1.09 (6H, s), 3.84 (4H, s), 4.94 (2H, s), 
7.02 (1H, t, J = 8.4 Hz), 7.10-7.15 (1H, dd, J = 2.4, 7.5 Hz), 7.88 (1H, t, J = 6.9 Hz) 
ppm, was in agreement with the literature data.68 
 (25). BOC protected diamide compound 18 (127 mg, 14 mmol) was dissolved in 4ml dry 
DCM and 2 ml of trifluoroacetic acid (TFA) was added to the flask. Reaction was stirred 
for 30min at rt and solvent was removed and dried under vacuum. The deprotected 
product, 19 (156mg, 0.50 mmol), potassium carbonate (175 mg, 1.27 mmol) and KI (6 
mg) was dissolved in dried acetonitrile and mixed for 12 hours at rt. Solvent  was 
removed and resulted yellow precipitate was dissolved in (10 ml) DCM and 5ml 10% 
NaHCO3 and stirred for 1 hour at rt. The organic phase was washed with water (2 × 
10ml), and dried over MgSO4 and solvent was removed in vacuo. The resulted residue 
 35
was re-precipitated from DCM-ether to give 25 in 39%. 1HNMR (400 MHz, CD3OD) δ: 
2.37 (6H, s), 2.63 (6H, s), 3.81 (4H, s), 4.22 (4H, s), 5.06 (4H, s), 5.74 (4H, s), 7.24 (4H, 
s), 7.57 (9H, t, J = 8.8 Hz), 7.83 (4H, d, J = 7.2 Hz), 8.31 (4H, d, J = 7.6 Hz), 8.45 (4H, 
d, J = 8 Hz) ppm. HRMS (ESI+): calcd for C62H58B2 N6O6: 1005.4663; found: 
1005.4663. We were unable to remove cleaved neopentyl glycol, in order to confirm the 
structure; the boronic acid was oxidized in the presence of acetic acid/water (1:1) and 
H2O2 to obtain pure NMR. 1HNMR (400 MHz, CD3Cl3) δ: 2.41 (6H, s), 2.64 (6H, s), 3.81 
(8H, s), 4.71 (4H, s), 5.72 (4H, s), 6.66 (2H, d, J = 8.4Hz), 7.23 (6H, s), 7.34-7.32 (3H, 
dd, J = 2, 6.4 Hz), 7.54 (4H, t, J = 8.8 Hz), 7.63 (4H, t, J = 6.4 Hz) 8.44 (8H, q, J = 9.2, 
12 Hz) ppm. 13C NMR (100 MHz, CDCl3) δ: 22.58, 29.62, 33.37, 39.35, 41.85, 53.59, 
59.52, 102.32, 116.85, 119.12, 122.84, 124.37, 124.76, 125.28, 125.64, 126.26, 126.42, 
127.32, 128.55, 129.98, 130.52, 130.89, 131.17, 132.22, 132.42, 132.98, 133.12, 134.42, 
161.58, 170.77 ppm. HRMS (ESI+): calcd for C62H56N6O4: 949.4442; found: 949.4479.  
 (26). The procedure was same as the preparation of 25 from 18.  Yield (20%). 1HNMR 
(400 MHz, CD3OD/CDCl3) δ: 2.37 (6H, s), 2.63 (6H, s), 3.80 (4H, s), 4.21 (10H, s), 5.73 
(4H, s), 7.23 (4H, s), 7.56 (6H, t, J = 8.0 Hz), 7.86 (2H, d, J = 8.0 Hz), 8.07 (2H, s), 8.12 
(2H, d, J = 8 Hz) 8.30 (4H, d, J = 8.4 Hz) 8.43 (4H, d, J = 8.4 Hz) ppm. HRMS (ESI+): 
calcd for C60H58B2N6O10 : 1045.4479; found: 1045.4523. We were unable to remove 
cleaved neopentyl glycol, in order to confirm the structure; the boronic acid was oxidized 
in the presence of acetic acid/water (1:1) and H2O2 to obtain pure NMR. 1HNMR (400 
MHz, CDCl3) δ: 2.44 (6H, s), 2.64 (6H, s), 3.80 (4H, s), 3.88 (4H, s), 4.73 (4H, s), 5.72 
(4H, s), 6.64 (2H, d, J = 6 Hz), 7.26 (3H, s), 7.52 (4H, t, J = 8 Hz), 7.62 (4H, t, J = 6.8 
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Hz), 7.87 (2H, s), 7.95-7.93 (4H, dd, J = 2.4, 2.4 Hz), 8.41 (4H, t, J = 10 Hz) ppm. 13C 
NMR (100 MHz, CDCl3) δ:  29.71, 33.48, 39.36, 41.66, 42.01, 53.50, 59.39, 116.17, 
121.81, 124.36, 124.65, 125.22, 125.32, 126.36, 126.57, 127.44, 128.38, 130.04, 130.82, 
131.10, 134.35, 140.05, 163.70, 170.74 ppm. HRMS (ESI+): calcd for C60H56N6O8 : 
989.4238; found : 989.4252.  
 (27). The procedure was same as the preparation of 25 from 18, but the hydrolysis was 
done in solution of acetone and water (1:4) in total volume of 150 ml and 1N HCl (10 
ml).  The reaction was stirred vigorously for 1hour at rt. The organic phase was washed 
with water (2 × 10ml), and dried over MgSO4 and solvent was removed in vacuo. The 
resulted residue was re-precipitated from DCM-ether to give 27 in 20%. 1HNMR (400 
MHz, CD3OD/CDCl3) δ: 2.21 (6H, s), 2.42 (6H, s), 3.72 (4H, s), 4.11 (4H, s), 4.60 (4H, 
s), 5.68 (4H, s), 7.09 (4H, q, J = 8.4, 9.6 Hz), 7.24 (4H, s), 7.48 (8H, s), 7.68 (2H, s), 8.27 
(4H, s), 8.42 (4H, d, J = 6.4 Hz) ppm. HRMS (ESI+): calcd for C60H58B2F2N4O6- H2O: 
973.4483; found: 973.4464. We were unable to remove cleaved neopentyl glycol, in 
order to confirm the structure; the boronic acid was oxidized in the presence of acetic 
acid/water (1:1) and H2O2 to obtain pure NMR. 1HNMR (400 MHz, CDCl3) δ: 2.34 (6H, 
s), 2.61 (6H, s), 3.79 (8H, s), 4.67 (4H, s), 5.29 (4H, s), 6.62 (2H, q, J = 4.4, 4.8 Hz), 
6.71 (2H, dd, J = 2.8 Hz), 6.77 (2H, d, J = 2.8 Hz), 7.23 (4H, s), 7.52 (4H, t, J = 8.4 Hz), 
7.60 (4H, t, J = 8.4 Hz), 8.40-8.42 (8H, dd, J = 2.4, 2.8 Hz) ppm. 13C NMR (100 MHz, 
CDCl3) δ: 29.71, 39.31, 41.66, 41.75, 53.59, 59.97, 114.78 (s (dC-F), J = 14 Hz), 115.01 
(s (dC-F), J = 14 Hz), 116.49 (s (dC-F), J = 8 Hz), 122.69, 122.75, 124.63, 125.19, 126.29, 
127.42, 129.14, 129.58, 130.08, 130.85, 131.07, 134.38, 153.11,  157.15 (s (dC-F), J = 
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220 Hz), 170.72 ppm. HRMS (ESI+) calcd for C60H56F2N4O4 : 935.4348 ; found: 
935.4351. 
2-[(Anthracen-9-ylmethyl-methyl-amino)-methyl]-4-cyano-boronic acid (29).  
Anthracen-9-ylmethyl-methyl-amine (120 mg, 0.54 mmol), 19 (183 mg, 0.60 mmol), 
potassium carbonate (299 mg, 2.17 mmol) and KI (7.2 mg) was dissolved in dried 
acetonitrile and mixed for 12 hours at rt. Solvent  was removed and resulted yellow 
precipitate was dissolved in (10 ml) DCM and 5ml 10% NaHCO3 and stirred for 1 hour at 
rt. The organic phase was washed with water (2 × 10ml), and dried over MgSO4 and 
solvent was removed in vaccum. The resulted residue was re-precipitated from DCM-
hexane to give 29 in 12%.  1HNMR (300 MHz, CDCl3) δ: 2.44 (3H, s), 4.23 (2H, s), 5.03 
(2H, s), 7.55 (4H, m), 7.67 (1H, d, J = 7.8 Hz), 7.89 (1H, d, J = 7.5 Hz), 8.10-8.19 (4H, 
dd, J = 8.4 Hz), 8.59 (1H, s) ppm. 13C NMR (100 MHz, CDCl3) δ: 43.15, 51.55, 112.24, 
119.33, 124.92, 125.88, 128.08, 128.34, 129.08, 129.32, 130.09, 131.00, 131.39, 131.72, 
133.79, 144.71 ppm.  HRMS (ESI+): calcd for C24H21BN2O2: 381.1774; found: 
381.1774. 
2-[(Anthracen-9-ylmethyl-methyl-amino)-methyl]-4-nitro-boronic acid (30). The 
procedure was same as the preparation of 29.  Yield (29%).  1HNMR (400 MHz, CDCl3) 
δ: 2.25 (3H, s), 4.54 (2H, s), 5.15 (2H, s), 7.58 (4H, m), 7.97 (1H, d, J = 8 Hz), 8.14 (2H, 
d, J = 8 Hz), 8.24-8.28 (4H, dd, J = 5.6, 6 Hz), 8.64 (1H, s) ppm. 13C NMR (100 MHz, 
CDCl3 / CD3OD) δ: 42.29, 121.80, 124.24, 124.90, 126.08, 126.77, 128.57, 129.17, 
131.38, 131.95, 135.88, 141.96, 143.07, 148.50 ppm. HRMS (ESI+): calcd for 
C23H21BN2O4: 401.1672; found: 401.1670. 
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2-[(Anthracen-9-ylmethyl-methyl-amino)-methyl]-4-fluoro-boronic acid (31).  The 
procedure was same as the preparation of 29.  Yield (53%).  1HNMR (300 MHz, CD3OD) 
δ: 2.24 (3H, s), 3.98 (2H, s), 4.57 (2H, s), 7.06 (2H, m), 7.42-7.44 (4H, dd, J = 2.7, 3.3 
Hz), 7.79 (1H, s), 7.94-8.00 (4H, dd, J = 3, 13.2 Hz), 8.39 (1H, s) ppm. 13C NMR (100 
MHz, CDCl3 / CD3OD) δ: 38.39, 61.24, 112.81 (s (dC-F), J = 18 Hz), 115.52 (s (dC-F), J = 
19 Hz), 122.32, 123.64, 125.38, 127.84, 128.28, 130.01, 130.16, 134.69, 141.96, 162.69 
(s (dC-F), J = 243 Hz)  ppm.  HRMS (ESI+): calcd for C23H21BFNO2: 374.1727; found: 
374.1717. 
2-(2-fluorophenyl)-5,5-dimethyl-1,3,2-dioxaborinane (35e). 
1HNMR (400 MHz, CDCl3) δ: 1.03 (6H, s), 3.79 (4H, s), 6.99 (1H, t, J = 9.2, 9.6 Hz), 
7.11 (1H, t, J = 7.6 Hz), 7.37 (1H, m), 7.72 (1H, t) ppm. 13C NMR (100 MHz, CDCl3) δ: 
21.86, 31.81, 72.45, 115.45 (s (dC-F), J = 24Hz), 123.48 (s (dC-F), J = 3 Hz), 132.55 (s 
(dC-F), J = 8 Hz), 136.21 (s (dC-F), J = 8 Hz), 165.90, 168.38 ppm.  GCMS (EI): calcd for 
C11H14BFO2: 208; found: 208. 
Methyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate (35f). 
1HNMR (300 MHz, CDCl3) δ: 1.13 (6H, s), 3.82 (4H, s), 3.94 (3H, s), 7.40 (1H, s), 7.53 
(2H, d, J = 2.7 Hz), 7.79 (1H, s), 7.95 (1H, d, J = 7.8 Hz) ppm. 13C NMR (100 MHz, 
CDCl3) δ: 22.07, 31.82, 52.35, 72.54, 128.42, 128.64, 131.36, 131.96, 132.84, 169.09 
ppm.  GCMS (EI): calcd for C13H17BO4: 247; found: 247. 
1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)ethanone (35h).  1HNMR (400 
MHz, CDCl3) δ: 1.13 (6H, s), 2.61 (3H, s), 3.81 (4H, s), 7.41 (2H, d, J = 1.2 Hz), 7.54 
(2H, d, J = 4.8 Hz), 7.82 (1H, d, J = 7.6 Hz) ppm. 13C NMR (100 MHz, CDCl3 ) δ: 
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22.22, 38.39, 25.61, 31.84, 72.57, 128.40, 128.47, 131.37, 132.67, 140.12, 200.70 ppm. 
GCMS (EI): calcd for C13H17BO3: 232; found: 232. 
2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzaldehyde (35m).  1HNMR (300 MHz, 
CDCl3) δ: 1.10 (6H, s), 3.83 (4H, s), 7.56 (2H, m), 7.82 (1H, d, J = 6.9 Hz), 7.93 (1H, d, 
J = 6.0 Hz), 10.47 (1H, s) ppm. 13C NMR (100 MHz, CDCl3) δ: 22.26, 25.65, 31.89, 
72.62, 128.45, 128.53, 131.41, 131.75, 140.39, 200.10 ppm.  GCMS (EI): calcd for 
C12H15BO3: 217; found: 217. 
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Chapter 2. Regulating the fluorescence intensity of an anthracene 
boronic acid System: A B-N bond or a hydrolysis mechanism? 
 
   
Abstract:  An anthracene-based fluorescent boronic acid system developed by the 
Shinkai group as mentioned in Chapter 1 has been widely used for the preparation of 
fluorescent sensors for carbohydrates.  Such application is based on the significant 
fluorescence intensity increase of this system upon binding with a carbohydrate. The 
mechanism through which this fluorescence intensity change happens was originally 
proposed to go through a B-N bond formation mechanism, which masks the nitrogen lone 
pair electrons.  However, our own fluorescence studies suggest a possible alternative 
mechanism for the fluorescence changes upon the formation of a boronic acid (1a) 
complex with diols.  In this new proposed mechanism, complex formation induces 
solvolysis, which results in the protonation of the amine nitrogen if the reactions are 
carried out in a protic solvent such as water at physiological pH.  This protonation 
prevents the photoinduced electron transfer, resulting in reduced quenching of the 
anthracene fluorescence and increased fluorescence.  Such a solvolysis mechanism is 
supported by evidence from various types of experiments and theoretical calculations.  
This study for the first time establishes a detailed mechanism of the fluorescence 
intensity changes of the anthracene boronic acid system (1a), which has been 
misunderstood for the last decade.  
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2.1. Contributions 
 This chapter includes both theoretical data as well as experimental data for the 
study. Dr. Weijuan Ni performed and collected theoretical data (section 2.10) and her 
work has been included in this chapter as further evidence in support of our proposed 
mechanism (hydrolysis mechanism).  
2.2. Introduction 
 Due to the unique strong interactions between boronic acids and diols through 
reversible ester formation, there has been a great deal of interest in using boronic acids as 
the recognition moiety for the development of fluorescent and color sensors,1-16 
carbohydrate transporters,17-22 and chromatographic stationary materials.23-26 Various 
fluorescent boronic acid compounds that show fluorescent intensity/wavelength changes 
upon binding with diols to varying degrees have been developed. 1, 27-29 Critical to the 
development of boronic acid-based fluorescent sensors is the availability of fluorescent 
reporter compounds that change fluorescence intensities upon binding to a diol.10, 29-31 In 
this regard, the Shinkai group, based on what was reported by Wulff earlier,32 has made 
some of the most important contributions by taking advantage of the fluorescence/color 
modulation effect of an amino group positioned in a 1,5 relationship to the boron atom of 
a boronic acid moiety.  One specific example is an anthracene-based fluorescent boronic 
acid compound (1a, Scheme 2.1), which shows significant fluorescence intensity changes 
upon diol binding.9, 27 It is well known that the nitrogen lone pair electrons can quench 
anthracene fluorescence through photoelectron transfer (PET).  Therefore, compound 1a 
is only weakly fluorescent at physiological pH.  Due to the proximity of the amine to the 
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boron atom, a B-N bond can be formed leading to a five-membered ring (1b) at neutral 
pH. Because diol binding often increases the Lewis acidity of the boron atom,28, 33, 34 
carbohydrate binding has been proposed to result in the strengthening of the B-N bond in 
2b, which makes the lone pair electrons less available for fluorescence quenching 
through PET.  The hypothesis was that B-N bond strengthening results in decreased 
fluorescence quenching and increased fluorescence intensities in 2b. The same concept 
has been the inspiration for the development of many other fluorescence or color boronic 
acid reporter compounds.10, 31, 35 We have also applied the Shinkai system for the 
preparation of sensors for mono- and oligosaccharides 17 and studied the effects of B-N 
bond formation in such systems using density functional theory (DFT) methods. 36 
Although this system (1a) has worked very well as a fluorescent reporter 
compound, there are telltale signs that the mechanism through which such a system 
works may not have to involve B-N bond formation as originally proposed. For example, 
available crystal structures actually show a longer B-N bond for the ester than for the 
acid. The bond lengths of the ester 37 and acid 7 determined by X-ray crystallography are 
1.754 Å and 1.669 Å, respectively.  Furthermore, James and co-workers have shown that 
the fluorescence intensity of the sugar-1b complex is independent of the intrinsic pKa of 
the boronic ester, which contradicts the B-N bond mechanism.38 Because of the enormous 
role that molecule (1a) has played in the field of boronic acid-based sensor design, there 
is a need to better understand the mechanism through which the fluorescence intensity 
change occurs. An understanding of the mechanism will help the future design of 
improved sensors.   
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Scheme 2.1.  Possible mechanisms for the fluorescence intensity changes 
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2.3. Experimental 
All the reagents were purchased from Aldrich or Fisher/Acros and used as received.  
Anhydrous tetrahydrofuran (THF) was distilled from Na/benzophenone prior to use.  
Acetonitrile (CH3CN) and dichloromethane (CH2Cl2) were distilled from CaH2.   
All pH values were determined with an Accumet 1003 Handhold pH/mV/Ion Meter 
(Fisher Scientific).  A Shimadzu RF-5301 PC fluorometer was used for the fluorescence 
studies.  The excitation wavelength was set at 370 nm.  A Shimudzu UV-1601 
spectrophotometer was used for the UV absorption studies. 
Synthesis of model compound 1a followed literature procedure.9, 27 
2.4. Experimental Design, Results and Discussions 
To analyze the possible mechanisms through which fluorescence intensity changes 
can occur, one can first write the different possible forms in which the boronic acid and 
the boronic acid-diol complex can exist.  Boronic acid can exist in the protonated form 
when the pH is below its first pKa (1a). There are ample literature results proving that the 
first pKa is the deprotonation of the amine with the concomitant formation of a B-N bond 
(1b).7 The formation of (1b) results in a significant fluorescence intensity decrease 
relative to (1a) despite the formation of the B-N bond.9, 27 Such results indicate that B-N 
bond formation itself is not sufficient to “tie up” the lone pair electrons to prevent PET.  
With the further increase of the pH, the hydroxide comes in to displace the amino group 
to give 1c, which no longer has a B-N bond.   
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With the addition of the diol, there are two possible scenarios, neither of which had 
been experimentally proven or excluded at present before our studies, although we were 
the first one proposing the solvolysis mechanism.  In the first scenario, pKa1 of the ester 
(2a) is the deprotonation of the amino group and the formation of the B-N bond (2b) as 
originally proposed by Shinkai and co-workers.  The second pKa is the replacement of the 
B-N bond by a B-O bond leading to the formation of 2c.  In the second scenario, shown 
in the bottom of Scheme 2.1, the first pKa is the addition of the hydroxide to the boron 
atom leading to the formation of 2d.  The second pKa is still the same, leading to the 
formation of 2c. The key difference between these two mechanisms is that under neutral 
conditions, addition of a diol will lead to the formation of 2b in one mechanism (referred 
to as the B-N bond mechanism) or 2d in the other.  The latter will be referred to as the 
hydrolysis mechanism since going from 1b to 2d corresponds to a hydrolysis of the B-N 
bond as the boron forms a complex with a diol in 2d when the experiments are carried out 
in an aqueous medium.  
In order to analyze existing literature data and to design experiments that can help to 
elucidate the mechanism, one has to analyze the possible experimental outcome under 
different experimental conditions for these two possible mechanisms.  In Table 2.1, we 
have listed the expected experimental and/or computational outcomes that correspond to 
each of the mechanisms.   
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Table 2.1.  Comparison of expected and observed phenomenon for the two different                               
mechanisms in Scheme 2.1. 
 
Phenomenon 
Expected results for 
the B-N bond 
mechanism 
Expected results for 
the hydrolysis 
mechanism 
Results 
observed 
Fluorescence 
intensity change 
associated with the 
first pKa 
Observable for both 
the acid (1) and the 
ester (2) 
Observable only for 
the acid (1), not the 
ester (2) 
Observable only 
for the acid (1) 
Fluorescence 
intensity change 
associated with the 
second pKa 
Observable for both 
the acid (1) and the 
ester (2) 
Observable only for 
the ester (2), not the 
acid (1) 
Observable only 
for the ester (2) 
Fluorescence 
intensity change in 
anhydrous solvent 
Intensity should 
increase for ester 
Intensity should 
decrease for ester 
Intensity 
decrease for 
ester 
Magnitude of 
fluorescence recovery 
with different sugars 
Different Same Same 
The effect of 
carbohydrates 
engaged in trivalent 
binding 
Will not induce 
fluorescence 
intensity changes 
Will induce 
fluorescence 
intensity changes 
Fluorescence 
intensity changes 
observed 
B-N bond strength 
difference between 
the acid (1) and the 
ester (2) 
Very large Small Smalla 
aComputational results. 
 
First, for the B-N bond formation mechanism (going from 2a to 2b to 2c) one would 
expect to see a significant fluorescence intensity decrease associated with both the first 
and second pKa’s since the deprotonation of the amino group and breaking the B-N bond 
are both expected to affect the availability of the lone pair electrons.  However, in the 
hydrolysis mechanism (going from 2a to 2d to 2c) one would only expect to see a 
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significant fluorescence intensity change associated with the second pKa since the first 
pKa does not affect the protonation state of the amino group, and therefore does not affect 
the availability of the nitrogen lone pair electrons in the PET process.  
Second, since binding with different diols may result in the lowering of the boron pKa 
to different degrees,28, 34 one would expect the B-N bond strength to be different in the 
boronic acid complexes with different sugars.  This difference in B-N strength should be 
reflected in fluorescence intensity changes observed with addition of sugars if the B-N 
bond formation mechanism is at work.  However, if the hydrolysis mechanism is at work, 
one would not expect to see a difference in the magnitude of the maximal fluorescence 
recovery.  
Third, binding studies carried out in anhydrous organic solvent would cause 
fluorescence intensity to increase for the B-N bond mechanism due to formation of 
complex 2b. If the hydrolysis mechanism is in play, the fluorescence intensity would 
decrease because the lone pairs on the nitrogen are free to quench the fluorescence via 
PET.  
Fourth, there are some sugars that are known to bind to boronic acid in a trivalent 
fashion. 5, 39, 40 If the B-N bond formation mechanism is the reason for the observed 
fluorescence intensity change, one would not expect these trivalent sugars to cause a 
fluorescence intensity increase because the trivalency prevents the B-N bond formation in 
the sugar-boronic acid complex (2c).  
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Fifth, if the strengthening of the B-N bond is the reason for the observed fluorescence 
intensity changes with this system, one would expect the B-N bond in the boronic acid-
diol complex (2b) to be much stronger than in the free boronic acid (1b).  
With these expected differences in mind, we examined these factors one by one, 
through experiments, computation and analysis of literature results. Fluorescent boronic 
acid 1a was synthesized following the literature procedure.27 Density functional theory 
(DFT) calculations were carried out using Dmol3 as described elsewhere.36 
2.5. pH profiles of the acid (1a) and various complexes 
We first examine the pH profile of 1a.  Shinkai’s original work has already shown 
that there is a significant decrease in fluorescence intensity associated with the first pKa 
of the boronic acid (1a), but not the second one.9, 27 We conducted the same experiments 
under similar conditions, and obtained similar results (Figure 2.1.).  This decrease in 
fluorescence intensity associated with the first pKa makes sense since it has been 
experimentally proven using a similar system that the first pKa is the deprotonation of the 
amino group accompanied by B-N bond formation.7 Deprotonation unmasks the nitrogen 
lone pair electrons and makes them available for PET.  It should be noted that the 
“affinity” of a proton for an amine group has been estimated to be in the range of 200 
kcal/mol.41 This value may vary significantly depending on solvation and pKa, but even if 
this “protonation affinity” is half of that number, it is still very strong, comparable to a 
sigma covalent bond, and higher than the energy required to remove an electron from 
amine nitrogen.  On the other hand, the B-N strength is only a few kcal/mol,36 which 
would not be able to “tie up” the nitrogen lone pair electrons nearly as effectively as 
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protonation does in order to prevent PET.  Such reasoning weighs in favor of a key role 
for protonation of the amine rather than B-N bond formation as the trigger that alters the 
fluorescence intensity.   
 
 
 
Figure 2.1.  pH titration profile of sensor 1a (2.25 × 10-6 M) at 25 °C in the presence (?) 
and absence (?) of D-glucose (0.05 M). 
 
 
Along these lines, it becomes easy to understand why there is only a very small 
fluorescence decrease associated with the second pKa in the case of the free acid (1b) 
because breaking a ~3.6 kcal/mol B-N bond does not make much of a difference in the 
PET process. As shown in a previous study, there is only a small effect on the driving 
force for electron transfer or the reorganization energy. With the addition of a sugar such 
as glucose, the pH profile of the complex is different.9, 27 The first pKa of the complex 
(2a) is no longer associated with a large decrease in fluorescence intensity.  This 
observation is not in agreement with the B-N bond mechanism since one would expect to 
see a fluorescence intensity decrease when the amine nitrogen goes from the protonated 
form to the B-N bond.  However, if the hydrolysis mechanism is at work, the 
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observations can be very easily explained.  In the boronic acid-diol complex, going from 
2a to 2d does not involve the deprotonation of the amino group.  Therefore, one would 
not expect to see a large fluorescence intensity change associated with the first pKa of the 
complex (2a) in the hydrolysis mechanism.  With the second pKa, it is the deprotonation 
of the amino group that is the reason for the significant decrease in fluorescence intensity.  
Such a mechanism is also in agreement with the different results observed between the 
acid (1a) and complex (2a). The B-N interaction itself is not sufficiently strong to tie up 
the lone pair electrons to prevent PET, which is why the fluorescence intensity changes 
were observed for the first pKa of the acid (1a), but not the ester (2a).  These observations 
also agree with DFT calculations that indicate that fluorescence quenching will occur in 
the neutral B-N forms due to the reduction of the reorganization energy upon B-N bond 
formation (or strengthening).36 The hydrolysis hypothesis also explains why fluorescence 
intensity changes were observed for the second pKa of the ester (2d) and the first pKa of 
the acid (1a) because again it is the deprotonation step that gives rise to fluorescence 
intensity changes. 
2.6. Effect of anhydrous solvent on binding between sugar and 1a 
 To further study the protonation state of the amine, fluorescence study was 
conducted in the anhydrous acetonitrile.  Since the amino group cannot be protonated in 
the absence of a protic solvent (the degree of protonation will be diminished, but not 
completely absence, if there is trace amount of water), experiments in an anhydrous 
solvent would allow us to probe the B-N bond effect on the fluorescent intensity of the 
system upon sugar binding.  If the hydrolysis mechanism is the reason for fluorescent 
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intensity changes upon sugar addition in an aqueous environment, the addition of sugar in 
an anhydrous solvent would be expected to cause the intensity to decrease since the lone 
pair of electrons on the nitrogen become free upon sugar addition. Indeed, decrease in 
fluorescence intensity was observed with addition of sugar in the anhydrous condition 
(Figure 2.2). These results are consistent with the hydrolysis mechanism proposed in 
Scheme 2.1.   
 
 
Figure 2.2.  Fluorescence intensity changes upon the addition of cyclopentanediol to 
sensor 1a (2.0 × 10-5 M) in anhydrous acetonitrile. Cyclopentanediol conc. (mM): 0, 
0.007, 0.012, 0.03, 0.045, 0.061, 0.086, 0.113, and 0.225. 
 
 2.7. Effect of different sugars on the fluorescence intensity changes of 1a 
It has been known for a long time that ester formation (2b) lowers the pKa of the 
boron species to different degrees depending on the sugar/diol used.28, 34 We have 
recently determined the apparent pKa values of the phenylboronic acid-diol complex with 
various sugars/diols, and found that the apparent pKa drops 2-4 pKa units upon 
complexation.28 For example, the apparent pKa of phenylboronic acid is about 8.8.  The 
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pKa values (or more precisely the apparent pKa’s under the experimental conditions) of its 
fructose and glucose esters are 4.5 and 6.8 respectively.  If the B-N bond mechanism is at 
work, one would expect that the fluorescence intensity of the boronic acid-diol complex 
to be dependent on the apparent pKa of the boron.  One would also expect to see as much 
change in fluorescence intensity when adding glucose to the free boronic acid and when 
replacing the glucose with fructose because their apparent pKa separations (∆pKa) are 
about the same.  In other words, the fluorescence intensity of the glucose complex should 
be much lower than that of the fructose complex because of the difference in their 
apparent pKa.  The same is true with the complex with other sugars. Aimed at studying 
the effect of various sugars on the fluorescence intensity of 1a, we examined the binding 
between 1a and fructose, glucose, sorbitol, and galactose, and found that these sugars 
gave about the same maximal fluorescence intensities at saturating concentrations (Figure 
2.3).  Such results are consistent with those obtained in an earlier study by James and co-
workers 38 and cannot be explained by the B-N bond mechanism, but are consistent with 
the hydrolysis mechanism since the amine is in the same (protonated) state (2d) no matter 
which sugar/diol is added. 
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Figure 2.3.  The effect of sorbitol (?), fructose (?), galactose (?), and glucose (?) on the 
fluorescence intensity of 1 (2.25 × 10-6 M). 
 
 
2.8. B-N bond strength  
As has been alluded to in the pH profile studies, in order for the B-N to play a role in 
regulating the PET process two things have to happen.    
First, the B-N bond needs to be so strong that it can “tie up” the lone pair electrons.  
This would mean that the B-N bond strength in the ester (2b) is on the same scale as the 
energy required transferring one nitrogen lone pair electron. The effect of protonation on 
the PET process serves as a good reference point.  Using mass spectrometry, it has been 
determined that the proton affinity of an aniline amine is on the order of 215 kcal/mol.41 
However, the B-N bond strength has been estimated to be at about 3.6 kcal/mol using 
Density Functional Theory,36 which is far smaller than what is required to tie up the 
nitrogen lone pair electrons to prevent PET.   
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Second, the B-N bond strength difference upon diol binding should be large 
compared to the B-N strength of the free acid (1b) in order to act as an on-off switch.  
Again, our theoretical calculation indicates that (1) the B-N bond in an ester (2b) is not 
much different from in the free acid (1b) form and (2) the change in bond strength upon 
ester formation is probably no more than 2 kcal/mol.36 The first point would directly 
contradict a B-N bond mechanism.  Even if there is an increase in B-N bond strength 
upon ester formation, such a small change is not expected to function as an on-off switch 
as described in a B-N bond mechanism.  On the other hand, the computational results and 
the “proton affinity” experiments41 are all consistent with the hydrolysis mechanism. 
2.9. Experiments with trivalent sugars   
There are several carbohydrates, including fructose and sorbitol that are known to 
bind boronic acids in a trivalent fashion.28, 34, 40 If the B-N bond mechanism is at work, 
one would expect that those sugars that complex to boronic acid in a trivalent fashion 
would not induce a fluorescence intensity change upon binding since B-N bond formation 
would not be possible. This is also a point raised by Norrild in a crystal structural study.39 
Therefore, we tested the effect of fructose and sorbitol on the fluorescence intensity of 1a. 
They both induced strong fluorescence intensity increases in a methanol-buffer mixed 
solvent (Figures 2.4 and 2.5). It should be noted that the effect of fructose has already 
been tested by Shinkai and co-workers and found to induce as much fluorescence 
intensity changes as the other sugars tested.9, 27 This by itself already contradicts the B-N 
bond mechanism, although the realization of fructose binding in a trivalent fashion came 
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after the proposed B-N bond mechanism. Such binding results cannot be explained by the 
B-N bond mechanism, but are consistent with the hydrolysis mechanism.   
 
 
 
Figure 2.4. Fluorescence intensity changes upon the addition of fructose to sensor 1 (2.81 
× 10-6 M) in 1:1 MeOH / 0.1 M aqueous phosphate buffer at pH 7.4. Fructose 
concentration. (mM): 0, 0.04, 0.09, 0.21, 0.35, 0.88, and 2.09. 
 
 
 
 
Figure 2.5. Fluorescence intensity change with addition of sorbitol to sensor 1 (2.81 × 
10-6 M) in 50% MeOH / 0.1 M aqueous phosphate buffer at pH 7.4. Sorbitol 
concentration. (mM): 0, 0.03, 0.10, 0.17, 0.39, 0.83. 
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2.10. Density functional theory (DFT) studies of model systems  
We have recently conducted DFT calculations of the B-N bond strength in a variety 
of adducts including models for those shown in Scheme 2.1 and found that the B-N bond 
strength to be very weak (< 7.2 kcal/mol) for all boronic acid and boronate ester adducts 
with geometry observed experimentally and the change in B-N bond strength upon 
formation of a boronate-ester is < 1 kcal/mol.36 The effect of the change in boron-
nitrogen interaction on the electron transfer rate constant was examined in detail.  
Estimates of the driving force (energy change for electron transfer) and reorganization 
energy were obtained. The DFT studies suggest that ester formation will actually 
decrease the fluorescence yield in aprotic solvents, but will increase the fluorescence 
yield in protic solvents.   
In all the points raised above and the results observed or reported in the literature, any 
single one is probably not enough to refute the B-N bond mechanism, but putting them all 
together, it forms a very strong case in support of the hydrolysis mechanism going 
through 2d and against the B-N bond mechanism. The hydrolysis mechanism is 
essentially a pKa switch mechanism that we have used in the design of spectroscopic and 
fluorescent boronic acid compounds, which changes spectroscopic and/or fluorescent 
properties based on the ionization state changes.29, 42 In such a situation, there are two (or 
more) ionizable functional groups in the boronic acid compound.  In this case, it is an 
amino and a boronic acid group. In the absence of any diol, the pKa of the amino group is 
lower than that of the boronic acid moiety. Therefore, the first pKa of the free sensor (1a) 
is that of the amino group. However, upon addition of a diol, the intrinsic pKa of the 
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boronic acid is decreased, which results in the pKa of the boronic acid moiety in the 
complex (2b) being lower than that of the amino group. In another words, the pKa order 
of these two functional groups is switched with the addition of a diol. With sensor 1a, this 
switch results in the protonation of amine nitrogen, which “ties up” the nitrogen lone pair 
electrons and prevents PET quenching of the anthracene fluorescence. 
2.11. Structural evidence of hydrolysis mechanism from other research groups 
Recently, based on our proposed hydrolysis mechanism the Anslyn group has further 
probed the structural and physical properties of different boronic acids and their complex 
with sugars in understanding the mechanism.43 They used X-ray crystallography, 11B 
NMR, and computational analysis as their tools to elucidate the mechanism. X-ray crystal 
structures of several boronic acids and their boronate forms were obtained from the 
aprotic and protic solvent. They postualed that the crystals obtained from the aprotic 
solvent would have the B-N bond whereas boronic acid crystal obtained from the protic 
solvents would be in the hydrated form.  Boronic acid crystal obtained from the aprotic 
solvent of compound 3 showed B-N bond whereas compound 4 and 5 showed no B-N 
bond. It was concluded that the B-N bond formation is effected by many forces and 
crystal lattice packing can play a significant role.  Crystal structure of complex 4 with 
catechol revealed B-N bond formation in anhydrous condition whereas crystal obtain in 
methanol showed methoxy group of solvent coordinated with the boron. Hence, it was 
concluded that B-N bond formation in ester depends on the solvent from which the 
crystal was obtained.  
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 11B NMR studies results coincide with the X-ray crystal structure results where in 
aprotic solvent boron atom adopts tetrahedral form by coordinating with nitrogen atom to 
form B-N bond in the free acid and ester form. On the other hand in protic solvent boron 
atom is fully solvated for both free and complexed boronic acid.   
2.12.  Conclusions 
In organic chemistry in general, it is always hard to prove a mechanism.  This is no 
exception.  However, results from the pH profile studies of the free boronic acid and its 
sugar complex, the effect of different sugars on the fluorescence intensity changes, the 
effect of trivalent sugar on the fluorescence intensity of the boronic acid, structural 
studies43 and the calculated B-N bond strength are all consistent with the hydrolysis 
mechanism being the reason for the observed fluorescent intensity changes in this system. 
Therefore, one can say with a high degree of confidence that based on available data, the 
hydrolysis mechanism proposed is much more probable than the B-N bond mechanism. 
The understanding of this mechanism helps the future design of more effective boronic 
acid fluorescent reporter compounds for sensor and other applications as has been 
demonstrated in some of our own work. 29, 42   
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Chapter 3.  Design and synthesis of boronic acid based sensors for sialic 
acid for anti-influenza therapy  
 
 Abstract: A new series of fluorescent boronic acid based sensors for sialic acid were 
designed and synthesized as potential anti-influenza agents. Three sensors were designed 
on “two point” interaction. Two interactions points were: boronic acid group and 
different amine based groups (amino/guandino/benzlyamine). Compounds (13, 15, 19) 
were synthesized via [2+3] Huisgen cyloaddition reaction and were fluorescent at 
micromolar range.  Compounds 13 and 19 did not show significant fluorescence change 
upon binding with sialic acid whereas the guanidine based compound (15) showed 
significant spectroscopic change upon addition of sialic acid with binding affinity (Ka) of 
8 M-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 70
3.1. Introduction 
 
3.1.1. Sialic acid structure  
 
Sialic acids (SA) are nine carbon α-keto acids with many biological functions. 
Sialic acid exits in many forms, main core structure is 2-keto-3-deoxy-D-glycero-D-
galacto-nonulosonic acid (1).1  Common modifications that occur in nature of SA are: 5-
amino group is either acetylated or glycolylated while all non-glycosidic hydroxyl group 
at position 4, 7, 8, and 9 have been substituted with acetates, sulfates, phosphates, and 
methyl ethers.  Usually mono O-acetylation (3) occurs but di- or tri- acetylation in one 
SA has also been reported. Such modifications can interfere with cell’s mode of action. 
For example O-acetylation prevents the monosaccharide to be a counter-receptor for 
influenza virus A and B whereas it is more susceptible to the binding of influenza virus 
C.2  The most common form of sialic acid and almost only form found in humans is the 
N-acetylneuraminic acid (2).3 Sialic acids rarely occur free in nature and are usually 
found on the terminal ends of the cell surface glycoconjugates in mamals. They are found 
in various linkages with the complex carbohydrates but mainly to galactose as N-
acetylgalactosamine.1 Sialic acid are also found in sialy Lewis a and x tetrasaccharides 
which have been associated with development and progression of certain types of 
cancer.4 Due to their location at the terminal end and the negative charge of the 
carboxylate functional group, sialic acids plays important role in mediating cellular 
recognition and adhesion processes. Bacteria on the other hand do not normally produce 
sialic acids on their own but some pathogenic strains can and they exhibit sialic acid on 
their cell surface to mimic mammalian cells and evade the host’s immune system. 1  
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Figure 3.1. Common sialic acid forms: 2-keto-3-deoxy-D-glycero-D-galacto-
nonulosonic acid (1), N-acetylneuraminic acid (2), and N-acetyl-9-O-
acetylneuraminic acid (3) 
 
 
3.1.2. Role of sialic acid in biological funtions and diseases 
Mammals, including human beings and other various microorganisms have the 
ability to produce sialic acids in a series of reaction from a simple precrursor, glucose.5  
Mammailian nervous system contains the highest amount of sialic acid in the form of 
gangliosides (65%), glycoproteins (32%) and the rest is in free form. However, in 
humans the gangliosides are not present evenly; they are mainly concentrated in the brain 
compared to other organs such as liver, lung, and spleen. Thus sialic acid moieties of 
gangliosides and glycoproteins play a role in structural and functional roles of celluar 
events such as cell recoginition, cell-to-cell contact, receptor binding, and other biosignal 
transduction. 6  High content of sailic acid has also been found in human milk.  Aside 
from this  property of cellular recognition and adhesion processes, the extent of outer 
surface celluar sialyation has been related to the tumorogenesis and metatasis of certain 
cancers.  The N-glycolyneuraminic acid form of sialic acid is found mainly in animal 
species but it has also been found in certain human cancers.3 It has also been reported that 
the levels of circulating sialic acid are higher in Type II diabetic patients than in 
nondiabetic patients.7   
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3.1.3. Sialic acid: a key recognition molecule for influenza viral infection 
Cell surface SA receptors has been considered to be critical for the influenza 
virus.8 There are three types of influenza viruses: influenza B and C are human viruses 
and influenza A virus is found in wide range of avian and mammalian hosts. Entry of the 
virus into the host occurs through the glycoproteins present on the viral surface. In 
specific, glycoproteins haemagglutinin (type A and B) and haemagglutinin esterase (type 
C) attaches to host cell-surface molecules containing sialic acid. The process is followed 
by endocytosis and fusion of viral membrane with the endosomal membrane which leads 
to the entry of the virus.8, 9  Studies have indicated that sialylcells are main celluar targets 
for the virus attachment to the host, in specific the N-acetyl-9-O-acetylneuraminic acid 
(3) has been the key determinant in this process. Recent outburst of H5N1 avian 
influenza flu or better known “bird flu” studies have also indicated haemagglutinin as a 
key receptor on the virus surface for cellular attachment. As in other influenza infection 
studies, the hemaggluctinin H5N1 also attaches to sialic acid receptors, specifically to 
sialic acid linked to galactose in α2,3 (4) or α2,6 (5) fashion (Figure 3.2).   Different 
linkages have been important determinant for prefential binding of virus as well the 
spread of the virus among species. Human influenza prefers to bind to sialic acid attached 
to galactose in α2,6 linkage (SA- α-2,6-Gal) whereas avian influenza binds in α2,3 
linkage (SA- α-2,3-Gal), thus the ability of virus to spread from avain to human is 
difficult due to linkage barrier.10 
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Since sialic acid is a key component for the influenza infection, we were 
interested in designing boronic acid based sensors for the sialic acid as potential sensors 
or drug targets for influenza therapy. 
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Figure 3.2.  Chemical structures of SA-α-2,3-Gal (4) and SA-α-2,6-Gal (5) 
 
 3.2.  Design of boronic acid based sensors for sialic acid    
 Boronic acids are known for their strong interaction with cis diols containing 
compounds and such interactions has been employed in the design of sensors for cell 
surface carbohydrates (chapter 1).4, 11, 12  As mentioned in chapter 1 a selective sensor 
consist of three components: a) proper functional groups that afford strong intermolecular 
interaction, b) a ‘reporting’ event/moiety that allows the binding event to be recognized, 
and c) the appropriate three-dimensional scaffold that allow for necessary 
complementarity in terms of size, shape, and functional group orientation. Taking in 
account of all the essential components for a selective sensor, potential sensors for sialic 
acid were designed using computer molecular modeling.  Sialic acid bears a pair of cis 
diols at positions 8 and 9 which make it a perfect substrate for boronic acid based sensor 
design. Aside from having a pair of cis diols SA also has a carboxylate anion and sensors 
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based on “two-point” interaction taking in account both the cis diol and carboxylate ionic 
interactions have been reported.  Shinkai et al reported the first PET (see Chapters 1 and 
2) based chemosensors for sialic acid based on two-point interaction.13 Their design 
included 1,10-phenanothroline-Zn(II) complex linked to aminomethylphenyl boronic acid 
(Figure 3.3). The metal complex served as carboxylate binding site and boronic acid 
group for diol binding. The receptor showed binding affinity (Ka) of 200 M-1 in an 
aqueous methanol solution at pH of 8.0. A similar system based on two-point interaction 
was reported by Takeuchi group where they designed surface plasmon resonance sensor 
for detection of sialic acid.14 In there design p-vinylbenzeneboronic acid group interacted 
with the cis diols and N,N,N-trimethylaminoethyl methacrylate interacted with 
carboxylate group of the sialic acid. In a combinatorial effort, Bradley Smith and 
coworkers have also worked on developing sialic acid sensors with limited success.15  
They designed there scaffold on a polymer chain with two recognition domains: 
conserved and variable. An anthracene based boronic acid acted as fluorophore and 
conserved recognition domain. It was attached to a poly(allylamine) (PAA) chain with 50 
free amines sites. After the attachment of the boronic acid moiety, the PAA chain was 
futher derivatized to give several cationic sites on the chain that acted as variable 
recognition domain.  Several libraries were designed and tested with sialic acid, fructose, 
and glucose. Fluorescence enhancement of 2-3 fold was seen among the libraries tested 
but with low selectivity among the sugars. 
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Figure 3.3. Complex structure of 1,10-phenanothroline-Zn(II) with sialic acid   
 As of today only limted examples of boronic acid based sensors are known for the 
sialic acid detection, which only have moderate affinity and selectivity. The above three 
examples of sensors for sialic acid have certains limitation. In Shinkai’s case, the receptor 
was only soluble in high concentration of methanol and high pH (8.0) was required to 
measure the fluorescence intensity changes. Such factors prevent them from being 
employed in normal physiological conditions where aqueous media rather than organic 
solvent are desired. To further enhance the solubility, binding affinity, and selectivity at 
physiological pH of sensors for the sialic acid, we designed several potential sialic acid 
sensors. Our designed also included two-point interactions where boronic acid unit would 
interact with the diols and an amino/guandino/amidino unit will interact with the 
carboxylate via hydrogen bonding and/or ionic interactions at physiological pH.  Two 
units (boronic acid and amine) in the sensor were set apart in a distance equivalent to that 
between the cis diols and carboxylate anion in SA as shown in Figure 3.4. Three triazole 
ring based sensors were designed and synthesized with different pKa values for the amine 
units substituted to promote protonation at physiological pH (Figure 3.4 a vs Figure 3.4 
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b).  The boronic acid (blue) was overlap with its complex (pink) with sialic acid to study 
the sturctural difference between their free and complex form. The overlay indicates that 
the sensor substituted with guanidine moiety has similar conformation when compared 
between its free and complex form whereas aniline substituted sensor has poor overlap. 
Such poor overlap translates into improper orientation of functional groups which are 
necessary for the higher binding affinity of sensor for its substrate.  Table 3.1 lists the 
distance measured for the sensors and their complex.  Their binding constants with sialic 
acid were also determined (Table 3.2).  
 
               A                                                                                                 B 
Figure 3.4.  a) Structure of sensor 13 (blue) with its complex (pink) with sialic acid; b) 
15 (blue) overlap with its complex (pink) sialic acid 
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Table 3.1.  Measurements of bond lengths between boronic acid (BA) and amine (NH)  
Sensor Sensor (BA-NH) 
distance 
(Ao) 
Complex (BA-NH) 
distance (Ao) 
-H bond Length 
(Ao) 
13 9.362 8.005 2.126, 2.602 
15 8.750 8.351 2.169, 1.900 
19 8.364 7.774 2.108, 1.878 
 
 
3.3. Synthesis of triazole based sialic acid sensors 
Synthesis of aniline, benzyl amine, and guanidine based sensors were 
accomplished with [2+3] Huisgen cycloaddition or “click chemistry” of an arylboronic 
acid bearing a terminal alkyne group and arylazide. The building blocks, alkyne16 and 
azide17, were synthesized by literature procedures.  Briefly, the ethynylarylboronic ester 
(10) was synthesised with the Sonogashira coupling using the 3-bromoarylboronic acid.  
For the ease of purification, 3-bromophenhylboronic acid was first protected with pinacol 
to give its ester (8) in 66 % yield. The Sonogashira coupling under microwave irridation 
at 120 oC for 25 min gave the Sonogashira coupling product (9) in 78%.  The 
trimethylsilyl group was removed in presence of K2CO3 in methanol to give terminal free 
ethynylbrononic ester in 97% yield (Scheme 3.1).  Arylazides were prepared with 
Ullmann type coupling of arylhalides in the presence of CuI. Azidoaniline (12) was 
prepared by refluxing 3-bromoaniline with sodium azide in the presence of CuI to give 
the desired azide in 97% yield. The 3-bromobenzylamine was first protected with di-tert-
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butyldicarbonate in methanol in the presence of triethyl amine (TEA) and then its azide 
was prepared with similar procedure as in the aniline case to give the desired product in 
58% yield (Scheme 3.1).  The guanidinoazide (14) was synthesized by reacting aniline 
azide with the guanylating agent which was prepared by reacting 1H-pyrazole-1-
carboxamidine with di-tert-butyl dicarbonate in presence of 3 equivalents of lithium 
hydride.18  Final triazole based compounds were obtained via copper catalyzed  Huisgen 
cycloaddition19 of amidoazide and alkyne in the presence sodium ascorbate to give 
boronic ester and free boronic acid of respective amine . In the case of benzylamine (19) 
and guanidine (15), the Boc protecting group was removed with trifluoroacetic acid to 
give free amino groups (Scheme 3.1). 
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Scheme 3.1. a) Pinacol, toluene, 120 o C; b) (CH3)3SiCCH, Pd(PPh3)3Cl2, CuI, PPh3, 
diethylamine, DMF, 120 o C, MW; c) K2CO3, MeOH; d) NaN3, CuI, sodium ascorbate, 
N,N-diethylethane-1,2-diamine, EtOH/H2O (7:3), reflux, N2; e) 10, CuSO4.5H2O, sodium 
ascorbate, t-butanol/H2O(1:1); f) 1-H-Pyrazole-1-(N,N’-bis(tert-
butoxycarbonyl)carboxamidine, MeCN; g) TFA(50%), DCM; h) di-tert-butyl 
dicarbonate, MeOH, TEA    
 
 
3.4. Binding studies 
 The fluorescence experiments were conducted to determine the appropriate 
binding constants of 13, 15, and 19 with sialic acid. Guandino based sensor (15) was 
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completely soluble in phosphate buffer (pH 7.4) with a sensor concentration of 2 × 10-4 
M. The aniline based sensor required 16% methanol and benzylaine required 8% 
methanol for there complete solubility. The binding constants were determined with sialic 
acid.  Upon sugar addition, guanidine substituted sialic acid sensor analogs (15) showed 
increased in fluorescence intensity whereas aniline and benzylamine substituted did not 
show much change in fluorescence intensity. Figure 3.6 shows two sets of fluorescent 
spectral changes upon sugar addition using compound 13 and 15 as examples. 
The guanidino-substituted compound 15 showed the highest change in 
fluorescence intensity with a 3-fold increase upon SA addition.  It also showed the 
highest binding affinity with an apparent binding constant (Ka) of 8 M-1 (Table 3.2). As 
predicted the aniline-substitued (13) showed very weak binding due to presence of only 
one binding unit (boronic acid) since aniline with a low pka was not protanated at 
physiological pH and probably did not interacted with carboxylate group of the SA.  The 
benzylamine- substituted compound 19 did not show significant change in fluorescence 
intensity to determine the binding constant.  
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Figure 3.6.  a) Fluorescence spectra of 13 (1.0 × 10-4 M) with sialic acid (0 mM-60 mM) 
at 25 oC in 16% MeOH/0.1 M aqueous phosphate buffer at pH 7.4: λex = 300 nm. b) 
Fluorescence spectra of 15 (1.0 × 10-4 M) with sialic acid (0 mM-65 mM) at 25 oC in 0.1 
M aqueous phosphate buffer at pH 7.4: λex = 375 nm. c) Fluorescence spectra of 19 (1.0 × 
10-4 M) with sialic acid (0 mM-60 mM) at 25 oC in 8% MeOH/0.1 M aqueous phosphate 
buffer at pH 7.4: λex = 288 nm 
 
 
Table 3.2.  Binding Constant (Ka) for compounds 13, 15, and 19 with sialic acid 
Compound Ka (M-1) 
 
Fluorescence 
intensity change 
13 4.0 1-fold increase 
15 8.0  3-fold increase 
19 a b 
                         a: binding constant (Ka) could not be determined 
                               b: no change in fluorescence intensity   
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3.5. Conclusions  
Three new fluorescent triazole-based boronic sensors (13, 15, and 19) were 
synthesized. Guanidine based sensor (15) had higher apparent binding constant for sialic 
acid (K 8 M-1) under physiological conditions.  On the other hand aniline and 
beznylamine based boronic acids did not show binding affinity towards sialic acid. 
Premiliary results indicate that guanidine based sensor is a potential target which can be 
futher optimized to give better induce fit model to futher enhance the binding affinity.    
3.6. Future Prespective 
 Among the design sensors, the guanidine based sensor showed a low affinity 
toward sialic acid but it is a potential target for further optimization. The design 
optimization include  
3.7. Experimental  
3.7.1. General Procedures 
 All air- and water-sensitive reactions were performed under dry nitrogen which 
was passed through dryrite in oven-dried glassware. Commercially available reagents 
were used without additional purification unless otherwise indicated. Dichloromethane 
was distilled from CaH2. THF was distilled from sodium and benzophenone.  
Analytical thin layer chromatography (TLC) was performed with Scientific 
Adsorbents plastic-backed TLC silica gel 60 F hard layer plates. TLC plates were 
visualized with UV light (254 nm) or with 5% (w/v) solution of phosphomolybidic acid 
in ethanol. Flash column chromatography was performed with Scientific Adsorbents 
silica gel (flash 32-63 nm). 
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Mass spectrometry (MS) analyses were performed by the Mass Spectrometry 
Facilities of Georgia State University. 1H and 13C NMR spectra were recorded at 400 
MHz and 100 MHz. Chemical shifts (δ) are given in ppm relative to TMS for 1H spectra 
and residual solvents for 13C spectra.  
3.7.2. Procedures for Fluorescence Binding Studies 
 A Shimadzu RF-5301PC fluorometer was used for all the fluorescent studies. For 
a typical fluorescent measurement, a 140 µL of sensor (2.0 × 10-4 M) stock solution in 
methanol/ 0.1 M phosphate buffer was mixed with 140 µL of saccharide solution in 0.1 
M of phosphate buffer (pH 7.4) at various concentrations.  The apparent pH was checked 
with pH meter and corrected if necessary. The mixture was allowed to mix for 10 min 
and fluorescence intensity was recorded.  Triplicate measurements were taken for each 
sugar. The correlation coefficients for all determinations in fitting the 1:1 model were 
over 0.98.  The binding constants were determined by procedure as described in section 
1.7. 
2-(3-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (8). A mixture of 3-
bromophenyl boronic acid 7 (14.9 mmol) and pinacol (17.9 mmol) was stirred in 
refluxing toluene equipped with a Dean-Stark trap for about 24 h until evolution of water 
ceased, then the solvent was removed on a rota-evaporator.  The crude product was 
purified by flash chromatography to give 8 in 66%. 1H NMR (400 MHz, CDCl3): 1.38 
(12H, s), 7.28 (1H, t, J = 7.2 Hz ), 7.61 (1H, d, J = 7.6 Hz), 7.74 (1H, d, J = 7.2 Hz),  7.95 
(1H, s) ppm. 13C NMR (100 MHz, CDCl3):  24.86, 84.16, 122.46, 129.50, 133.09, 
134.19, 137.48 ppm. MS-EI: calcd for C11H13BBrO2: 282; found: 282.   
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Trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethynyl)silane (9). 
A mixture of aryl bromide (8) (0.9 mmol), Pd(PPh3)Cl2 (0.05 mmol), CuI (0.05 mmol), 
triphenylphosphine (0.18 mmol), trimethylsilylacetylene (1 mmol), and diethylamine 
(13.6 mmol) in dimethylformamide (DMF, 0.5 mL) was irradiated with microwave with 
temperature maintained at 120 ºC for 20 ~ 25min in a heavy-walled glass vial sealed with 
Teflon septum.  Then the reaction mixture was filtered and washed with 
dichloromethane. The filtrate was concentrated under reduced pressure and the residue 
was purified by flash chromatography to give 9 in 78%. 1H NMR (400 MHz, CDCl3): 
0.23 (9H, J = 3.2 Hz) 1.34 (12H, s), 7.30 (1H, t, J = 7.6 Hz), 7.52-7.55 (1H, tt, J = 1.2,1.2 
Hz), 7.72-7.74 (1H, dd, J = 1.2, 1.2 Hz),  7.93 (1H, s) ppm. 13C NMR (100 MHz, CDCl3):  
0.01, 24.87, 83.99, 94.06, 105.07, 122.68, 127.58, 133.09, 134.58, 138.47 ppm. MS-EI: 
calcd for C17H25BO2 Si: 300; found: 300.   
2-(3-Ethynylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (10) A mixture of 
trimethylsilylethynylaryl boronate 9 (0.5 mmol) and potassium carbonate (2 mmol) in 
methanol (10 mL) was stirred at room temperature for 0.5 h ~ 2 h.  Then the reaction 
mixture was filtered, and the filtrate was concentrated under reduced pressure to give a 
residue, which was purified by flash chromatography to give 10 in 77%. 1H NMR (400 
MHz, CDCl3): 1.34 (12H, s), 3.04 (1H, s), 7.32 (1H, t, J = 7.6 Hz), 7.58 (1H, d, J = 7.6 
Hz), 7.78 (1H, d, J = 7.2 Hz),  7.95 (1H, s) ppm. 13C NMR (100 MHz, CDCl3): 24.86, 
83.60, 84.02, 121.68, 127.66, 134.64, 134.89, 138.52 ppm. MS-EI: calcd for C14H17BO2: 
228; found: 228.  
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3.7.3 General procedure for the synthesis of azides 
In a 2-neck flask, aryl bromide (1 mmol), NaN3 (2 mmol), sodium ascorbate (0.05 
mmol), CuI (0.1 mmol), N,N-dimethylethylamine (0.15mmol), and 4 mL of  EtOH-H2O 
(7:3) were added. The flask was degassed and backfill with nitrogen, the reaction was 
stirred under reflux condition and reaction was monitored by TLC. Upon completion of 
reaction, the reaction was cooled down to room temperature. Reaction mixture was 
diluted with water and aqeous layer was extracted with ethyl acetate (2 X 30 mL). 
Organic layers were combined together and dried over MgSO4 and solvent was 
evaporated.  Crude mixture was purified by flash chromatography to give the desired aryl 
azide.  
3-Azidoaniline (12).  Reaction was completed in 40 min to give 12 in 97% yield. 1H 
NMR (400 MHz, CDCl3): 3.73 (2H, s), 6.31 (1H, s), 6.45 (1H, d, J = 8.0 Hz ), 7.11 (2H, 
t, J = 7.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): 105.40, 109.02, 111.93, 130.61, 
140.99, 148.10 ppm. MS-EI: calcd for C6H6N4: 134; found: 134.   
tert-Butyl (3-azidophenylamino)-(tert-butoxycarbonylamino)methylenecarbamate 
(14). In a flask equipped with a stir bar, 1H-pyrazole-1-carboxamidine with di-tert-butyl 
dicarbonate and 8 mL of CH3CN were mixed at room temperature until completely 
dissolved. To the flask was added 12 and mixture was refluxed for 8 hrs.  Solvent was 
evaporated and crude reaction mixture was purified with flash chromatorgraphy giving 
14 in 35% yield. 1H NMR (400 MHz, CDCl3): 1.51 (9H, s), 1.54 (9H, s), 6.76 (1H, s, J = 
3.6 Hz), 7.27 (2H, s), 7.61 (1H, s), 10.38 (1H, s), 11.60 (1H, s) ppm. 13C NMR (100 
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MHz, CDCl3): 28.15, 28.08, 79.81, 83.98, 112.64, 115.17, 118.16, 129.97, 138.39, 
140.72, 153.30, 163.29 ppm. MALDI (M+H): calcd for C17H24N6O4: 377; found: 377.   
tert-Butyl 3-bromobenzylcarbamate (17).  In a flask commerically available 3-
bromobenzylamine and di-tert-butyl dicarbonate were dissolved in methanol (10 mL). To 
the flask TEA was added dropwise and reaction mixture was stirred for 12 hrs.  Solvent 
was evaporated and crude reaction mixture was purified with flash chromatorgraphy 
giving 17 in 88% yield. 1H NMR (400 MHz, CDCl3): 1.46 (9H, s), 4.29 (2H, d, J = 5.6 
Hz), 4.85 (1H, s), 7.21 (2H, m), 7.40 (1H, m), 7.42 (1H, s) ppm. 13C NMR (100 MHz, 
CDCl3):  28.38, 122.66, 125.97, 130.15, 130.40, 141.38  ppm. MS-EI: calcd for 
C12H16BrNO2: 286; found: 286.   
tert-Butyl 3-azidobenzylcarbamate (18). General procedure for azide synthesis was 
used to obtain 18 (58% yield).  1H NMR (400 MHz, CDCl3): 1.46 (9H, s), 4.30 (2H, d, J 
= 5.6 Hz), 4.96 (1H, s), 6.90 (1H, s), 6.93 (1H, s), 7.05 (1H, d, J = 7.6 Hz), 7.29 (1H, t, J 
= 8.4 Hz) ppm. 13C NMR (100 MHz, CDCl3):  28.39, 44.24, 79.71, 117.78, 117.89, 
123.83, 129.96, 140.32, 141.19, 155.92 ppm. MS-EI: calcd for C12H16N4O2: 248; found: 
248.  
3.7.4. General procedure for the synthesis of trizole ring based boronic acids 
Compound 10 (1 mmol) and respective azide (1 mmol) was suspended in a 1:1 mixture of 
water: tert-butanol in a flask. To the flask was added sodium ascorbate (0.3 mmol, 
dissolved in 0.05 mL water) followed by copper (II) sulfate pentahydrate (0.03 mmol, 
dissolved in 5 µL water). The hetergoneous mixture was stirred at 80 oC until the reaction 
went to completion. The reaction mixture was diluted with water and aqeous layer was 
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extracted with ethyl acetate. Organic layers were combined together and dried over 
MgSO4 and solvent was evaporated. The crude mixture was purified with flash 
chormatorgraphy to give the desired boronic ester and boronic acid.  
3-(1-(3-Aminophenyl)-1-H-1,2,3-triazol-4-yl)boronic acid (13). The reaction was 
stirred for 24 hr and yield boronic ester 17 % and boronic acid in 9.6 %. Boronic ester: 1H 
NMR (400 MHz, CDCl3): 1.37 (12H, s), 3.94 (N-H, 2H, s), 6.71-6.74 (1H, dd, J = 2.4, 
5.6 Hz), 7.05-7.08 (1H, dd, J = 2.0, 6.0 Hz), 7.19 (1H, t, J = 2.0 Hz), 7.28 (2H, t, J = 8.0 
Hz), 7.48 (1H, t, J = 7.6 Hz), 7.81 (1H, d, J = 7.6 Hz), 8.12-8.14 (1H, tt, J = 1.6 Hz), 8.21 
(1H, s)  ppm. 13C NMR (100 MHz, CDCl3): 24.87 (d), 83.98, 106.91, 109.95, 115.08, 
117.78, 128.39, 128.68, 129.75, 130.51, 132.07, 134.72, 147.85, 148.12 ppm. HRMS 
(ESI+): calcd for C20H23BN4O2: 363.1914; found: 363.1992. Boronic acid: 1H NMR (400 
MHz, CDCl3) δ: 6.78-6.82 (2H, m), 7.06-7.09 (1H, m), 7.18 (1H, t, J = 2.4 Hz), 7.23-7.28 
(2H, m), 7.33-7.35 (2H, m) ppm. 13C NMR (100 MHz, CDCl3) δ: 107.74, 110.31, 113.67, 
116.73, 118.33, 131.33, 131.60, 132.70, 139.24, 149.47, 150.93, 159.09 ppm. Under 
mass spectrometery conditions the boronic acid was oxidized. MS (ESI-): C14H12N4O: 
252; found: 252.  
3-(1-(3-Guanidinophenyl)-1H-1,2,3-triazol-4-yl)boronic acid (15). The reaction was 
stirred for 48 hr and yield boronic ester 8.2% and Boc protected boronic acid in 8.5%. 
Boronic ester: 1H NMR (400 MHz, CDCl3): 1.37 (12H, s), 1.53 (9H, s), 1.56 (9H, s), 7.48 
(2H, t, J = 7.6 Hz ), 7.62 (2H, t, J = 6.0 Hz), 7.82 (1H, t, J = 7.2 Hz), 8.14 (1H, d, J = 7.6 
Hz), 8.24 (1H, s), 8.30 (2H, d, J = 4.0 Hz)  ppm. 13C NMR (100 MHz, CDCl3): 24.86 (d), 
28.09 (d), 83.95, 84.20, 113.87, 116.33, 117.79, 121.66, 128.36, 128.69, 129.68, 130.18, 
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132.03, 134.78, 137.38, 138.34, 148.29, 153.48, 163.19 ppm. MS (ESI+): calcd for 
C31H41BN6O6: 605.5; found: 605.5. Boronic acid: 1H NMR (400 MHz, CDCl3): 6.80-6.83 
(1H, qq, J = 0.8, 1.6 Hz ), 7.28 (1H, t, J = 8.0 Hz), 7.35-7.37 (2H, m), 7.40-7.42 (1H, tt, J 
= 1.2 Hz ), 7.69 (1H, t, J = 8.0 Hz), 7.89-7.93 (2H, m) ppm. 13C NMR (100 MHz, 
CDCl3): 112.21, 115.28, 116.71, 118.50, 118.85, 124.92, 129.75, 131.02, 131.15, 136.57, 
138.10, 148.49, 156.69, 157.79 ppm. Under mass spectrometery conditions the boronic 
acid was oxidized. MS (ESI-): calcd for C15H14N6O: 295.3; found: 295.2.   
3-(1-(3-Aminomethyl)phenyl)-1H-1,2,3-triazol-4-yl)boronic acid (19).  The reaction 
was stirred for 24 hr and yield Boc protected boronic acid in 7.5% and upon deprotection 
of Boc group with TFA gave the final boronic acid (19). 1H NMR (400 MHz, CDCl3): 
4.28 (2H, s), 6.85 (2H, d, J = 7.6 Hz), 7.28 (1H, t, J = 8.0 Hz), 7.39 (2H, d, J = 6.8 Hz), 
7.61-7.67 (2H, m), 7.98 (1H, d, J = 7.2 Hz), 8.08 (1H, s), 8.86 (1H, s) ppm. 13C NMR 
(100 MHz, CDCl3): 42.44, 107.74, 110.31, 113.67, 116.73, 118.33, 131.33, 131.60, 
132.70, 139.24, 149.47, 150.93, 159.09 ppm. MALDI (M+H): calcd for C15H14N4O: 
267.3; found: 267.0. 
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Chapter 4. Synthesis and Structure-activity Relationship and NMR 
Studies of a Series of Phenyl Alkyl ketone Analogs as Highly Potent and 
Selective PDE4D2 Inhibitors  
 
Abstract: A new series of the phenyl alkyl ketones as PDE4D2 inhibitors were 
investigated. Seven compounds were identified to have sub-micromolar IC50 values. 
Among them, the most potent compounds 5q, 5l, and 5g have IC50 values of 83, 170, and 
200 nM respectively. Compound 5a showed lower inhibition activity of 45 µM, but better 
selectivity (22 fold) over other PDE families (PDE9A2, HisPDE2A3, and PDE5A1) 
except for PDE7A1 when compared to genistein.  Compound 5b had similar inhibition 
activity as genistein but showed preference for PDE4D2 with selectivity of 285, 285, 142, 
and 42-fold over PDE7A1, PDE9A2, HisPDE2A3 and PDE5A1 respectively. Transfer 
NOESY studies indicated that the free 5e and the bound inhibitor with PDE4D2 may 
have the same conformation. 
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4.1. Contributions 
The goal of this project was to synthesize a new class of PDE4 enzyme inhibitors. 
Earlier designed PDE4 enzyme inhibitors have shown promising results but have 
therapeutic limitations due to their does-limiting side effects such as nausea and emesis.  
Such limitations arise from their poor selectivity among the different PDE families. 
Herein we have focused on the design and synthesis of novel enzyme inhibitors to target 
the subfamily of PDE4, i.e. PDE4D to enhance selectivity among families and reduce the 
side effects. Totally, 41 inhibitors were synthesized, among which 23 were synthesized 
by Dr. Shilong Zheng.  Compounds that I have synthesized will be described further with 
their synthesis and inhibition activity and selectivity. 
Dr. Ke at University of North Carolina carried out the inhibition assays and 
calculated the IC50 values. NMR studies were carried out by Dr. James Prestegard at 
University of Georgia. Molecular modeling on binding profile of inhibitors was carried 
by Dr. Minyong Li.  
4.2. Introduction 
 
  Four decades ago, Sutherland and Rall first reported the hydrolytic activities of 
cyclic nucleotide phosphodiesterases (PDEs).  They reported that PDEs can hydrolyze 
adenosine and guanosine 3´, 5´-cyclic monophosphates (cAMP and cGMP) to 5´-AMP 
and 5’-GMP in a variety of tissues1 (Figure. 4.1). The second messengers cAMP and 
cGMP mediate the response of cells to a wide variety of hormones and neurotransmitters, 
and modulate many biological and metabolic processes, such as cardiac and smooth 
muscle contraction, platelet aggregation, secretion, apoptosis, and growth control.2-8  
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Intracellular cAMP and cGMP are synthesized respectively by adenylyl cyclase and 
guanylyl cyclase, 6 and hydrolyzed by PDEs.  
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Figure 4.1.  PDE- catalyzed hydrolysis of cAMP and cGMP 
 The human genome encodes twenty one PDE genes that are categorized into 
eleven families and subdivided into over sixty PDE isoforms. The discovery of PDEs 
families was first made during a study conducted from the crude tissue extracts eluted 
from the anion exchange column. Different fractions collected from the column indicated 
at least one kinetically distinct PDE and more significantly the amounts of PDE differ 
among various tissues.9 Such a discovery led to the proposal of developing new selective 
inhibitors that could target specific diseases. Theophylline (1), a non selective PDE 
inhibitor, has been used for the treatment of asthma and other pulmonary diseases. The 
non-selective nature of theophylline not only produces side effects but also limits its use 
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in selectively inhibiting particular PDE in target tissues.1 With the discovery of PDE 
families and some twenty crystal structures of PDEs available,10 selective inhibitors of 
PDEs have been synthesized and studied as therapeutics for treatment of various human 
diseases. Successful examples include PDE5 (PDE family 5) inhibitors sildenafil 
(ViagraTM), vardenafil (LevitraTM), and tadalafil (CialisTM) for treatment of erectile 
dysfunction. PDE4 inhibitors have shown great potential for treatment of asthma and 
chronic obstructive pulmonary disease, but side effects such as emesis prevent their 
practical applications. It is generally believed and hypothesized that side effects of PDE4 
inhibitors arise from inhibition of non-targeted PDE families or lack of selectivity against 
subfamilies PDE4A, B, C, and D.  However, the molecular basis for family and 
subfamily selectivity of PDE4 inhibitors is poorly understood. This study was aimed at 
the design and synthesis therapeutically useful PDE4 subfamily inhibitors. 
 The nomenclature of the PDE families is as follow:  Most families include more 
than one gene and sometimes numerous splice variants. Nomenclature of PDEs includes 
gene family designation (PDE isozyme 4) followed by the gene product (PDE4D) and 
lastly the splice variant (PDE4D2)  
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Figure 4.2.  PDE4 Inhibitors 
 
4.3. Substrate Selectivity 
    The homology of PDEs is categorized into three regions: conserved catalytic domain, 
the N-terminal, and the C-terminal region (Figure 4.3). The catalytic domain of all 11 
families of PDE shares about 30 to 50% of amino acids. The C-terminal domain 
functions are unclear however the N-terminal region regulates various functions in PDEs. 
For example, in PDE2, the N-terminal contains the cGMP binding site whereas it has 
phosphorylation sites for various protein kinases in PDE1, PDE3, PDE4, and PDE5.1 All 
PDEs contain a conserved catalytic domain, but each family possesses different substrate 
specificities and selective inhibitors.  PDE 4, 7, and 8 prefer to hydrolyze cAMP while 
PDE 5, 6, and 9 are cGMP-specific. PDE 1, 2, 3, 10, and 11 enzymes show activity 
toward both nucleotides.10  The conservation of the catalytic domain among the families 
predicts that the families would also share the same inhibitors. Indeed it has been 
reported that a selective inhibitor of PDE5, Viagra, has IC50 of 3.5 nM and it also shows 
inhibition for PDE4 with IC50 of 7.7 µM.11 
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Figure 4.3. Different domains of PDEs1 
 
4.4.1. Crystallographic data of PDEs 
Crystal structures of PDEs typically contain a compact arrangement of 16 α helices 
which are arranged in three subdomains. An example of  PDE crystal structure is shown 
in Figure 4.4, where the binding site domains are shown in blue and green colors.12 The 
active site of enzyme consists of deep hydrophobic pocket located at the intersection of 
the three subdomains.  The binding site domain consists of four regions: a) metal binding 
site (M), b) core pocket (Q), c) hydrophobic pocket (H), and d) lid region.10 At the time 
of writing crystal structures of five families have been reported: PDEs 1, 3, 4, 5, and 9. 
Since the focus of this study is on PDE4, only crystal structures of PDE4 subfamilies will 
be discussed.  The crystal structure of PDE4D shows a tetrameric formation, however a 
dimer for PDE4D has been proposed as the catalytic form based on crystal structure of 
PDE4D with zardavarine (PDED 4 inhibitor).12 While PDE4B catalytic domain is a 
monomer, PDE4A have various oligomerization states from monomer, dimer, to 
tetramer. Aside from their distinct conformational states, the subtypes of PDE4 have 
distinct tissue and cellular distribution as well. Several studies have shown that the 
PDE4C is abundant in the neuronal tissue but absent in the inflammatory and immune 
cells.13, 14 PDE4A has been shown to be distributed evenly in tissues1 and PDE4B is 
expressed in heart, brain, skeletal muscle, and lung.15 The N-terminal of PDE4A also 
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influences inhibitor potency for some of the PDE4 inhibitors. For example, a careful 
examination of PDE4A4 has shown that it coexists in two conformational states and 
rolipram (2), a known PDE4 inhibitor, prefers to bind one conformer over the other. 
Upon deletion of  N-terminus the potency of rolipram is reduced by 10- to 30-fold.16-18  In 
a similar example, the N terminal of PDE4D3 is a site for phosphorylation. The 
phosphorylation activates one conformer over the other of  PDE4D3 and studies have 
indicated that rolipram binds to the phosphorylated conformer with higher affinity than 
the non phosphorylated conformer.18, 19 
 
Figure 4.4.  Surface plot of the crystal structure of PDE4D2. Blue indicates binding 
pocket hydrophilic areas and green hydrophobic areas. Binding subdomains are: core 
region (Q), metal region (M), and hydrophobic region (H).10 
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4.4.2. Design of new PDE4 inhibitors based on crystallographic data of rolipram 
The complex structure of PDE4D2-rolipram showed that the binding residues for 
PDE4 inhibitor rolipram is absolutely conserved in the PDE4 subfamilies, thus 
suggesting that the subfamily selectivity is largely dependent on their conformational 
states.12 The derivatives of rolipram account for a large percentage of the PDE4 inhibitors 
known and show encouraging results in clinical trials for treatment of asthma and chronic 
obstructive pulmonary disease (COPD). Roflumilast (3) is the best representative of these 
compounds and has been filed for Investigative New Drug application (IND) as a drug 
for COPD and asthma. Thus we synthesized our general-PDE4 selective inhibitors based 
on the rolipram core. Co-crystallized structure of the rolipram (2) with enzyme reveals 
that it forms two hydrogen bonds with the side chain of Gln369 and many hydrophobic 
interactions with the active site (Figure 4.5).  The cyclopentyloxy group of rolipram 
occupies the hydrophobic pocket thus hydrophobic substitution can be made with groups 
such as a cyclopentane ring in new inhibitor design. The phenylmethoxy ring sits in the 
ditch shaped pocket. Thus only a planar ring can be used for the new PDE4 inhibitor. The 
methoxy group of the phenylmethoxy occupies the opening space.  This open space has a 
little extra space for a slightly bigger group either polar or nonpolar to be substituted. The 
pyrrolidone ring does not make any significant interactions with the catalytic site; rather 
it is open to the adjacent metal pocket. Thus dramatic changes can be made to the 
pyrrolidone ring.12 
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Figure 4.5.  The key residues in the binding site of Rolipram to PDE4D2 X-ray 
model (PDB entry: 1OYN). The residues are represented as line and rolipram is 
shown in stick and ball. H-bond is represented as green line and distance (Å). The 
hydrogen atoms were removed for clarity. 
 
4.5. Chemical synthesis of novel PDE4 inhibitors 
Earlier studies have indicated that the alkoxy group in both 3 and 4 position are 
needed.20 So in our designed analogs, various heteroatom based alkoxy groups were 
substituted on the 3-position via alkylation of 1 and 2a-2b (Scheme 4.1). Alkylation of 
3,4-dihydroxybenzaldehyde using chlorodifluoroacetate in the presence of CsCO3 
provided 4-difluoromethoxy-3-hydroxy benzaldehyde 2a in 50% and 3,4-
bis(difluoromethoxy)benzaldehyde 2b as side product. The commercially available 3-
hydroxy-4-methoxybenzaldehyde 2c and 4-difluoromethoxy-3-hydroxy-benzaldehyde 2a 
were reacted with various racemic alcohols (R2OH) in THF via Mitsunobu reaction to 
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give racemic aldehydes 3a-e in 38-40% yield. Treatment of aldehydes (3a-e) with either 
n-butyllithium, t-butyllithium or Grignard reagent gave the corresponding diastereomeric 
mixture of alcohols 4a-o. The oxidization of the alcohol with PCC afforded the 
corresponding ketones 5a-o. 
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Scheme 4.1.  Synthesis route to phenyl alkyl ketones 
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4.6. Structure activity relationship (SAR) of PDE4D inhibitors  
 
      The enzyme inhibitory activities of the synthesized compounds were evaluated 
against human PDE4D2 which had been cloned and expressed in E. coli strain BL21 
(Codonplus). The results are summarized in Table 4.1 and 4.2. Table 4.1 also includes 
compounds (entries 1-4) that were synthesized by Dr. Shilong Zheng for comparison 
purposes and for the discussion of SAR 
In Table 4.1, a few of the intermediates were tested along with the final 
compounds for their inhibition activity and it was found that the phenyl alkyl methanols 
(entries 1-2, 4) were 2 ~150 folds less potent than the corresponding phenyl alkyl ketones 
(entries 5-25). The 3-methoxy substituted phenyl compounds (entry 4) were 20 ~ 150 
fold more potent than the corresponding 4-methoxy substituted compounds (entries 1-3). 
From the initial SAR results it was concluded that the new series of compounds should be 
substituted with 3-methoxy substitutent and that the ketones have higher inhibition 
activity than their corresponding alcohols (entry 2 and 3) 
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Table 4.1.  IC50 (µM) values of PDE4D2 phenyl alkyl methanols and phenyl alkyl 
ketones                         inhibitors 
R1O
O
OH
R2
R3
       OR        
R1O
O
O
R2
R3
 
 
Entry Compd  R1 R2 R3 IC50 (µM) 
1 4a O
O
OH
O
 
O  
-CH3 n-Pr 1500 
2 4b O
O
O
OH  
O
 
-CH3 n-Pr 520 
3 4c O
O
O
O  
O
 
-CH3 n-Pr 24 
4 4d 
O
O
OH
O
 
   -CH3 O
 
n-Bu 10 
 
Table 4.2 shows the new series of compounds that were synthesized after the 
initial round of testing. The tetrahydrofuran-3-yloxy substituted phenyl compounds 
(entries 12-13) have 1.3 ~ 8.5 fold better activity than the corresponding tetrahydropyran-
3-yloxy substituted phenyl compounds (entries 8-9). Upon chaging the tetrahydropyran 
ring to piperidine ring, both compounds 5d and 5e, the Boc protected piperidi-4-nyl (IC50 
4.8 µM) and the deprotected piperidi-4-nyl substituted (IC50 102 µM) (entries 10 and 11) 
lost their activity and were 2 fold less active than the corresponding tetrahydropyran-3-
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yloxy substituted phenyl compounds. Compared to the Boc protected compound (5d) the 
deprotected compound 5e has lower inhibition activity.  
In the series of the 4-methoxy-3-tetrahydrofuran-3-yloxy phenyl ketones (entries 
12-20), the ketone with i-butyl side chain has the best activity (IC50 176 nM) and the 
ketone (entry 13) with the n-butyl side chain has the second best activity (IC50 200 nM). 
Upon increasing the side chain length for 5m, the activity was lost (IC50 380 nM). The 
activity of ketones (entries 16 and 17) with a cyclohexylalkyl chain and a phenylalkyl 
chain (entries 14 and 15) consistently showed the weakest activity.  The replacement of 
tetrahydrofuran ring with the Boc protected tetrahydropyrrol (entries 21 and 22) 
decreased the activity to 380 nM and 30 µM, respectively. Again, among the Boc 
protected terahydropyrrol compounds (entries 21 and 23), the compound with i-butyl side 
chain had better activity (IC50 380 nM) compared to its analog with n-butyl side chain 
(IC50 30 µM). Upon deprotecting the Boc group, the n-butyl side chain analog of 
tetrahydropyrrol series had better activity (IC50 1 µM, entry 22).  However the acetyl 
protected tetrahydropyrrol gave the best activity with IC50 of 83 nM. 
 From the above SAR studies, ketones with alkyl chains and 3-tetrahydrofuran-3-
yloxy group gave good activity.  However upon substituting the 3-tetrahydrofuran-3-
yloxy group with 3- acetyl protected tetrahydropyrrol the inhibition activity improved 
with IC50 of 83 nM which turned out to be the best inhibitor among the series of 
compounds synthesized.  
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Table 4.2.   IC50 (µM) values of PDE4D2 phenyl alkyl ketones inhibitors 
 
R1O
O
O
R2
R3
 
 
Entry Compd  R1 R2 R3 IC50 (µM) 
7 5a 
O
O
N
O
O
 
-CH3 
O  
3-quinoline 45 
8 5b 
O
O
O
O
 
-CH3 
O  
n-Pr 3.5 
9 5c 
O
O
O
O
 
-CH3 
O  
n-Bu 0.72 
10 5d 
O
O
O
N Boc
 
-CH3 
N
Boc  
n-Bu 4.8 
11 5e 
O
O
O
NH
 
-CH3 
N
H  
n-Bu 102 
12 5f 
O
O
O
O
 
-CH3 O
 
n-Pr 0.4 
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13 5g 
O
O
O
O
 
-CH3 O
 
n-Bu 0.2 
14 5h 
O
O
O
O
Ph
 
-CH3 O
 
-(CH2)3Ph 2.3 
15 5i 
O
O
O
O
Ph
 
-CH3 O
 
-(CH2)2Ph 2.6 
16 5j 
O
O
O
O
 
-CH3 O
 
(CH2)2cyclohexyl 1.9 
17 5k 
O
O
O
O
 
-CH3 O
 
-CH2-cyclohexyl 2.6 
18 5l 
O
O
O
O
 
-CH3 O
 
  i-Bu 0.176 
19 5m 
O
O
O
O
 
-CH3 O
 
i-pen 0.380 
20 5n 
O
O
HF2C
O
O
 
-CHF2 O
 
t-Bu 0.410 
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21 5o 
O
O
HF2C
O
N
Boc
 
-CHF2 Boc-N
 
n-Bu 30 
22 5p 
O
O
HF2C
O
H
N
 
-CHF2 
N
n-Bu 1.0 
23 5q 
O
O
HF2C
O
N
O
 
-CHF2 
N
O
 
i-Bu 0.083 
 
 
 
Two representatives of  the found PDE4D2 inhibitors were tested in human 
PDE7A1, 9A2, 2A3 and 5A1 subtypes , which had  been cloned and expressed in E. coli 
strain BL21(Codonplus) (Table 4.3). Compared with the low selectivity of Genistein, 
most of our compounds showed interesting PDE4D2 subtype specificities.  For example, 
5a had lower inhibition activity but showed preference for PDE4D2 with selectivity of 
11, 22, 22, and 22 fold over PDE7A1, PDE9A2, HisPDE2A3 and PDE5A1 respectively. 
Compound 5b had similar PDE4D2 inhibitory activities (IC50 3.5 µM) compared with 
Genistein (IC50 3.2 µM), however, its selectivity over PDE7A1, PDE9A2, HisPDE2A3 
and PDE5A1 was 14, 14, 12, and 5-fold higher than that of genistein, respectively. 
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Table 4.3.  IC50 values (µM) of selected inhibitors with various PDEs 
       IC50(µM) is about 1000 µM means no less of activity  with 100 µM inhibitors 
  
Among the 23 inhibitors that were synthesized, 7 inhibitors had better activity 
than rolipram (1µM). Selective inhibitors (5m, 5n, and 5q) were overlayed with rolipram 
(Figure 4.6) in the active site of the enzyme to study the conformation of inhibitors to the 
rolipram. All the three inhibitors 5m (yellow), 5n (green), and 5q (blue) occupied the 
same binding pockets compared to rolipram (red) but with different conformation. 
Compared to the rolipram the three inhibitors had the alkyl chains extending towards the 
metal pocket compared to pyrrolidone ring of the rolipram, the closer proximity of the 
new inhibitors towards the metal pocket could have led to enhanced inhibition activity of 
the inhibitors.  
 
 
PDE4D2 
(79-438)  
PDE7A1 
(130-482) 
PDE9A2 
(181-506) 
His-
PDE2A3 
(580-941) 
PDE5A1 
(535-860) 
Genistein 3.2 70 70 40 30 
5a 45 500 1000 1000 1000 
5b 3.5 1000 1000 500 150 
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Figure 4.6.  Overlay of the inhibitors 5m (yellow), 5n (green), and 5q (blue) with 
rolipram into the PDE4D2 crystal  
 
4.7. NMR study of the interaction of 5e with PDE4D2 protein 
    The interactions of inhibitor 5e with PDE4D2 were studied with NMR.  Saturation 
transfer difference (STD) and transfer nuclear Overhauser effect (trNOE) experiments 
were performed to demonstrate binding between PDE4D2 and the inhibitor 5e. The 
binding epitope of the inhibitor was also determined. The solubility of 5e up to 800 µM 
in D2O was confirmed by NMR. A reference 1H spectrum allowed assignment of 
resonances as indicated in Figure 4.7.  A 2D NOESY spectrum was also obtained for the 
5e (Figure 4.8). 
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Figure 4.7.  A reference and assignment of 1H spectrum of 400 µM 5e.  The water peak 
in the center of the spectrum was removed for clarity. Note:  Peak ‘i’ was not assigned 
and is believed to be a contaminant. 
 
 
 
Figure 4.8.  A 2D NOESY spectrum of 400 µM 5e with 500 ms mixing time.  Blue 
indicates positive peaks and red indicates negative peaks.  The crosspeak intensities are 
negative indicating positive NOE’s typical of small molecules free in solution. 
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The 800 µM STD spectrum of 5e with the PDE4D2 shows changes in the 
spectrum (Figure 4.9).  The different distribution of peak intensities can be seen as 
compared to the reference spectrum.  For example, peak ‘d’ is depressed and peak ‘n’ 
enhanced relative to other peaks.  This is due to close contact of protons assigned to these 
peaks with protons of the protein. 
     The trNOEsy spectra obtained are shown in Figure 4.10.  The changes in signs were 
observed for the cross peaks relative to those in the reference NOESY spectra.  This is 
indicative of dominance by the slowly tumbling bound form of the inhibitor.  The 
appearance of similar cross peak sets to those seen in the reference NOESY spectrum is 
indicative of some similarity in the bound form as compared to the solution form of the 
inhibitor. 
 
 
 
Figure 4.9.  A STD spectrum of 800 µM 5e and 10 µM PDE4D2.  The protein was 
selectively saturated at 0.5 ppm with 250 ms of saturation.  The protein background was 
not subtracted or suppressed.  The water peak was removed for clarity. 
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Figure 4.10.  2D NOESY spectra of 800 µM 5e and 10 µM PDE4D2 with (a) 50 ms and 
(b) 300 ms mixing times.  The crosspeaks have positive intensities (i.e. negative NOE’s) 
which indicate that 5k is binding PDE4D2. 
(b) 
(a) 
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Compound 5e and PDE4D2 provide a near ideal system for the NMR study.  The 
solubility of 5e was high enough to prepare a sample for NMR detection, and the 
exchange rate with the protein was fast enough to perform STD and trNOE experiments.  
The binding epitope and interesting NOE’s were observed.  The peaks for 5e in STD and 
NOESY spectra were assigned using the 1H reference spectrum.  The peak integrals from 
the reference and STD spectrum were compared and normalized to give a STD 
percentage for each proton (Figure 4.11).  The STD percentages give an indication of 
which protons of bound 5e are close to the protein, i.e. an epitope map.  For 5e, peak ‘i’ 
was not observed in the STD indicating that it does not bind PDE4D2 providing evidence 
that it is a contaminant.  Non-specific binding was not observed for 5e at the 
concentrations studied as evidenced by the STD of the diluted sample which showed a 
similar pattern of enhancements (data not shown). 
 
Figure 4.11.  The STD percentage for each proton is shown for the 5e. 
NOESY spectra also gave useful information about the binding and structural 
conformation of small molecules.  When compared to the reference NOESY spectrum of 
the inhibitor, the transferred NOESY spectrum of the inhibitor in the presence of the 
protein can indicate binding.  Small molecules exhibit positive NOE’s and large 
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molecules have negative NOE’s.  When a small molecule binds to a large molecule, such 
as a protein, its properties change and negative NOE’s are observed.  For 5e, positive 
NOE’s are observed for the sample of the inhibitor alone (Figure 4.8) and negative 
NOE’s are observed for the samples in the presence of PDE4D2 (Figure 4.10).  These 
results corroborate the STD results that 5e binds to PDE4D2.  Moreover, transferred 
NOESY spectra can provide information about the conformation of the bound inhibitor. 
The relative intensities of the NOESY crosspeaks can be used to calculate distances 
between protons.  Qualitative information can be readily determined by looking at 
crosspeaks in the 50 ms transferred NOESY spectrum of 5e in the presence of PDE4D2 
(Figure 4.10a).  For example, the crosspeaks observed from the aromatic protons show 
that peaks ‘a’ and ‘b’ are close in space to the methylene group, ‘g’, and peak ‘c’ is close 
to the methyl group, ‘d’.  In addition, peak ‘b’ is close to peaks ‘j’ and ‘k’ and to water.  
All of these interactions are also observed in the NOESY spectrum of the free inhibitor 
(Figure 4.8) indicating that the free and bound conformation may be the same.  The NOE 
to the water molecule in the transferred NOESY spectrum indicates that water is 
accessible to the inhibitor in the bound state, demonstrating that water is in the binding 
pocket with the inhibitor or the bound state inhibitor is solvent-accessible on the side of 
the molecule.      
4.8. Conclusions  
A new series of the phenyl alkyl ketones as PDE4D inhibitors were investigated. 
Seven compounds were identified as having sub-micromolar IC50 values. Among them, 
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the most potent compounds 5q, 5l, and 5g have IC50 values of 83, 170, and 200 nM, 
respectively. Compound 5a showed lower inhibition activity of 45 µM, but better 
selectivity (22 fold) over other PDE families (PDE9A2, HisPDE2A3, and PDE5A1) 
except for PDE7A1 when compared to genistein.  Compound 5b had similar inhibition 
activity as to genistein but showed preference for PDE4D2 with selectivity of 285, 285, 
142, and 42-fold over PDE7A1, PDE9A2, HisPDE2A3 and PDE5A1 respectively. 
Comparison of STD experiments of both free and bound inhibitor indicated that the 
methyl group of the butyl side chain was in close contact with the protein. Also the 
intensity of the methyl of methoxy group decreased in the bound form indicating binding 
to the protein. Transferred NOESY studies indicated that free 5e and the bound inhibitor 
with PDE4D2 may have the same conformation, since the cross peaks observed from the 
aromatic protons matched the cross peaks observed in the free inhibitor. Cross peaks 
observed also showed that α methylene group and methoxy group were closer to the 
aromatic protons.  It was also indicated that one of the aromatic proton was accessible to 
the water molecule in the binding pocket.  
4.9. Experimental 
 
4.9.1. General chemistry 
  All reagents were purchased from Acros and Aldrich. N-(t-butoxycarbonyl)-4-
piperidinol was synthesized according to the procedure1. Microwave heating was 
performed in the single-mode microwave cavity of a Discover Synthesis System (CEM 
Co.), and all microwave-irradiated reactions were conducted in a heavy-walled glass vials 
sealed with Teflon septa. 1H-NMR and 13C-NMR were recorded at 400 and 100 MHz, 
 116
respectively, on a Bruker 400 NMR spectrometer. Combustion analyses and mass spectra 
were performed by the analytical and the mass spectrometry facilities at Georgia State 
University. Molecular modeling on binding profile of inhibitors was carried by Dr. 
Minyong Li. The inhibition constants (IC50), the inhibitor concentration that produces 
50% enzyme inhibition in the presence of substrate [S], were determined by Dr. 
Hingming Ke at University of Chapel Hill. 
4.9.2. Determing Inhibiton Constants (IC50) 
 The inhibition constants (IC50), the inhibitor concentration that produces 50% 
enzyme inhibition in the presence of substrate [S], were determined by equation 1. The 
activity of the substrates, cAMP and cGMP, were measured at eight different 
concentration and each measurement was repeated three times. Vmax and Km values were 
calculated by linear plot of Eadie-Hofstee (V/[S] vs. V) where V is velocity of reaction 
and [S] is concentration of substrate. In the linear plot the y intercept is equivalent to Vmax 
and slope is equal to -Km.   The apparent inhibition constants (Kapp) were measured with 
LineWeaver-Burt plot in the presence of the inhibitors. The Ki values of the inhibitors 
were obtained form the plot of Kapp versus inhibitor concentration.  
 
                                                    IC 50 = (1+ [S]/Km) Ki                                         Equation 1 
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4.9.3. Preparation of 4-Difluoromethoxy-3-hydroxybenzaldehyde (2a) and 3,4-
Bisdifluoromethoxybenzaldehyde (2b) 
A mixture of 3,4-dihydroxybenzaldehyde (1.38 g, 0.01 mol), methyl  chlorofluoroacetate 
(1.87 g, 0.013 mol) and cesium carbonate (4.24 g, 0.013 mol) in DMF (20 mL) was 
stirred at 65 °C for 3 h under an nitrogen atmosphere, then DMF was removed in vacuo 
and the residue was portioned between aqueous 3N HCl and ether. The aqueous layer 
was extracted three times with ether. The combined organic solution was washed with 
water and brine, dried over MgSO4, filtered and evaporated. The residue was purified by 
flash chromatography to afford 2a as a white solid (0.85 g, 45%) and 2b as a yellowish 
liquid (0.48 g, 20%). (2a).  1H NMR (400 MHz, CDCl3): 6.17 (1H, s, br), 6.67 (1H, t, J = 
72.8 Hz), 7.28 (1H, d, J = 8.4 Hz), 7.45 (1H, dd, J = 4.0 and 8.4 Hz), 7.55 (1H, d, J = 4.0 
Hz), 9.92 (1H, s) ppm. 13C NMR (CDCl3): 115.6 (triplet, J = 262 Hz, d), 117.1 (d), 119.3 
(d), 123.2 (d), 134.5, 143.0, 147.8,  191.1 (d) ppm. MS (EI): calcd for C8H6F2O3 (M+): 
188; found 188. (2b). 1H NMR (400 MHz, CDCl3): 6.63 (1H, t, J = 72.8 Hz), 6.68 (1H, t, 
J = 72.4 Hz), 7.43 (1H, dd, J = 8.8 Hz),   7.79 ~7.77 (2H, m), 9.95 (1H, s) ppm. 13C NMR 
(100 MHz, CDCl3): 115.3 ((d)t, J = 262 Hz), 115.5 ((d)t, J = 263 Hz), 121.4 (d), 128.7 
(d), 134.1, 142.3, 147.1, 190.1 (d) ppm. MS (EI): calcd for C9H6F4O3 (M+): 238; found 
238. 
4.9.4. General Procedure for the Synthesis of 3 by Mitsunobu Reaction of 2a and 2c 
with R2OH 
To the mixture of compounds 2 (1 mmol), R2OH (1.1 mmol) and di-tert-butyl 
azodicarboxylate (1.2 mmol) in THF (5 mL), was added dropwise triphenylphosphine 
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(1.2 mmol) in THF (5 mL) at 0 °C. The resulting solution was stirred until the compound 
2 consumed completely (usually for 24 h).  The solvent was removed in vacuo and the 
residue was purified by flash chromatography to afford the product 3. 
 4-Difluoromethoxy-3-(tetrohydro-furan-4-yloxy)-benzaldehyde (3a) Yield: 84%. 1H 
NMR (400 MHz, CDCl3): 2.19 (1H, m), 2.30 (1H, m), 3.91-4.06 (4H, m), 5.07 (1H, m), 
6.67 (1H, t, J = 74.4 Hz), 7.33 (1H, d, J = 8.4 Hz), 7.44 (1H, d, J = 1.6 Hz), 7.48 (1H, dd, 
J = 1.6 and 8.4 Hz)  9.93 (1H, s) ppm. 13C NMR (CDCl3): 32.7 (t), 67.0 (t), 72.5 (t), 78.8 
(d), 112.9 (d), 115.5 ((d) t, J = 260 Hz), 122.2 (d), 125.2 (d), 134.3, 145.6, 149.4, 190.5 
(d) ppm. MS (EI): calcd for C12H12F2O4  (M+):258; found 258.  
tert-Butyl 3-(2-(difuloromethoxy)-5-formylphenoxy)pyrrolidine-1-carboxylate (3b). 
Yield: 26%. 1H NMR (400 MHz, CDCl3): 1.46 (9H, s), 2.20 (2H, d, J = 7.6 Hz), 3.65-
3.49 (4H, m), 5.01 (1H, s), 6.59 (1H, (d)t, J = 74 Hz), 7.32 (1H, s), 7.45 (1H, s), 7.49 
(1H, d, J = 8.4 Hz), 9.26 (1H, s) ppm. 13C NMR (100 MHz, CDCl3): 28.46, 31.53 (d), 
44.00 (d), 51.47 (d), 79.72 (d), 113.54 (d), 122.53 (d), 125.64, 154.54, 190.55 ppm.  
HRMS (ESI+): calcd for C13H13F2NO5 (M+-t-butyl) : 302.0840; found: 302.0823.  
4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-benzaldehyde (3c). Yield: 52%. 1H NMR 
(400 MHz, CDCl3): 1.84 – 1.86 (2H, q, J = 4.4, 4.4 Hz), 2.06 (2H, d, J = 8.8 Hz), 3.57 
(2H, t, J = 9.2 Hz), 3.95 (3H, s), 4.05 (2H, m), 4.51 (1H, m), 7.01 (1H, d, J = 8.4 Hz), 
7.44 (1H, s), 7.47 – 7.49 (1H, q, J = 1.6, 6.4 Hz) 9.84 (1H, s) ppm. 13C NMR (100 MHz, 
CDCl3): 31.86, 56.16, 65.31, 73.49, 111.25, 113.92, 127.15, 129.99, 147.09, 156.06, 
190.80 ppm.  HRMS (ESI+): calcd for C13H16O4 : 237.1127; found: 237.1121. 
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4- Methyoxy-3-(tetrahydro-furan-3-yloxy-benzaldehye (3d). Yield: 40%. 1H NMR 
(400 MHz, CDCl3): 2.25 (2H, q, J = 6.0, 8.0 Hz ), 3.94 (4H, d, J = 12 Hz), 4.04 (3H, d, J 
= 2.4 Hz), 5.02 (1H, s), 7.00 (1H, d, J = 8.0 Hz), 7.35 (1H, s), 7.48 (1H, q, J = 2.0, 6.4 
Hz), 9.84 (1H, s) ppm. 13C NMR (100 MHz, CDCl3): 32.98, 56.16, 67.72, 72.91, 78.67, 
111.07, 112.18, 127.21, 129.96, 147.58, 155.56, 190.73 ppm.  HRMS (ESI+): calcd for 
C12H14O4 : 223.0970; found: 223.0965. 
4-(5-Formyl-2-methoxy-phenoxy)-piperidine-1-carboxylic acid-tert-butyl ester (3e). 
Yield: 53%.  1H NMR (400 MHz, CDCl3): 1.47 (9H, s), 1.80 (2H, q, J = 3.2, 3.6 Hz), 
1.95(2H, q, J = 4.0, 4.8 Hz), 3.30 (2H, m), 3.80 (2H, s), 3.94 (3H, s), 4.52 (1H, s), 7.01 
(1H, d, J = 8.0 Hz), 7.44 (1H, s), 7.49 (1H, d, J = 8.0 Hz), 9.84 (1H, s) ppm. 13C NMR 
(100 MHz, CDCl3): 28.45, 30.61, 56.17, 74.20, 79.62, 111.26, 114.11, 127.21, 130.04, 
147.16, 154.78, 156.13, 190.79 ppm. HRMS (ESI+): calcd for C18H25NO5: 336.1811; 
found: 336.1814. 
4.9.5. General Procedure for the Synthesis of 4 by Nucleophilic Addition to the 
Aldehydes 3 
 To aldehyde 3 (1 mmol) in THF (5 mL), was added dropwise the n-butyllithium 
or Grignard reagent at -78 °C. The resulting mixture was stirred overnight at -78 °C to rt 
and quenched with water. The aqueous layer was extracted three times with ethyl acetate. 
The combined organic solution was dried over MgSO4, filtered and evaporated. The 
residue was purified by flash chromatography to afford 4 
.1-[4-Methoxy-3-(tetrahydro-pyran-4 yloxy)-phenyl]-butan-1-ol (4b). Yield 60%. 1H 
NMR (400 MHz, CDCl3): 0.92 (3H, t, J = 7.6 Hz), 1.44 (3H, m), 1.68 (1H, m), 1.87 (4H, 
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m), 2.01 (2H, m), 3.56-3.51 (2H, dd, J = 2.4, 8.8 Hz), 3.84 (3H, s), 4.03 (2H, m), 4.44 
(1H, m), 4.59 (1H, s), 6.86 (1H, d, J = 8.4 Hz),  6.92 (1H, d, J = 8.4 Hz), 6.95(1H, s) 
ppm. 13C NMR (100 MHz, CDCl3): 13.97, 19.10, 32.12, 41.24, 56.05, 65.38, 73.80, 
73.96, 112.10, 115.34, 119.66, 137.75, 146.40, 150.28 ppm.  HRMS (ESI+): calcd for 
C16H22O3 -H2O: 263.1647; found: 263.1645. 
1-[4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-phenyl]-pentan-1-ol (4c). Yield 72%. 1H 
NMR (400 MHz, CDCl3): 0.88 (3H, t, J = 6.8 Hz ), 1.25 (1.32 (3H, m), 1.65 (1H, m), 
1.85 (4H, m), 2.01 (2H, s), 3.53 (2H, t, J = 8.8 Hz), 3.84 (3H, s), 4.01 (2H, t, J = 5.6 Hz), 
4.43 (1H, d, J = 4.0 Hz), 4.57 (1H, s), 6.86 (1H, d, J = 8.4 Hz), 6.92 (1H, d, J = 8.4 Hz), 
6.95 (1H, s) ppm. 13C NMR (100 MHz, CDCl3): 14.03, 22.58, 28.05, 32.10, 38.81, 56.02, 
65.34, 73.76, 74.14, 112.09, 115.40, 119.69, 137.83, 146.35, 150.24 ppm.  HRMS 
(ESI+): calcd for C17H27O4– H2O: 277.1804; found: 277.1795. 
 4-[5-(1-Hydroxy-pentyl)-2-methoxy-phenoxy]-piperidine-1-carboxylic acid tert-
butyl ester (4d). Yield 84%. 1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.44 
(2H, q, J = 7.2, 7.6 Hz), 1.47 (9H, s) 1.69 (4H, m), 1.73 (2H, s), 1.92-1.96 (2H, m), 2.91 
(2H, t, J = 7.2 Hz), 3.23-3.29 (2H, m), 3.80 (2H, m), 4.63 (1H, s), 3.91 (3H, s), 4.50-4.51 
(1H, m), 4.70-4.72 (1H, s), 6.92 (1H, d, J = 8.4 Hz), 7.57 (1H, d, J = 2 Hz), 7.60-7.63 
(1H, dd, J = 2, 6.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 14.03, 22.59, 28.06, 28.45, 
30.83, 38.79, 56.04, 74.28, 74.53, 79.52, 112.13, 115.49, 119.75, 137.72, 146.47, 150.37, 
154.84 ppm.  HRMS (ESI+): calcd for C18H25NO4 - (H2O+ t-butyl): 320.1862 found: 
320.1882 
 121
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-butan-1-ol (4e). Yield 40%. 1H 
NMR (400 MHz, CDCl3): 0.92 (3H, t, J = 7.2 Hz), 1.30 (1H, dd, J = 6.4, 9.6 Hz), 1.42 
(1H, d, J = 7.2 Hz), 1.63 (1H, s), 1.81 (2H, bs), 2.19 (2H, m), 3.84 (2H, s), 3.90 (2H, s), 
4.00 (3H, s), 4.60 (1H, s), 4.97 (1H, s), 6.89 (3H, m) ppm. 13C NMR (100 MHz, CDCl3): 
13.97, 19.08, 33.07, 41.24, 56.08, 67.22, 73.01, 74.07, 78.88, 112.05, 113.66, 119.33, 
137.68, 146.89, 149.70 ppm.  HRMS (ESI+): calcd for C15H23O4– H2O: 249.1491; found: 
249.1480.  
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-pentan-1-ol (4f). Yield 41%. 1H 
NMR (400 MHz, CDCl3): 0.88 (3H, t, J = 6.4 Hz), 1.22-1.35 (4H, m), 1.65-1.77 (2H, m), 
1.86 (1H, s), 2.18 (2H, d, J = 5.6 Hz), 3.84 (2H, s), 3.89-3.92 (1H, m), 4.00 (3H, s), 4.58 
(1H, s), 4.96 (1H, s), 6.84-6.91 (3H, m) ppm. 13C NMR (100 MHz, CDCl3): 14.03, 22.59, 
28.03, 33.04, 38.80, 56.05, 67.19, 72.98, 74.26, 78.83, 112.02, 113.65, 119.35, 137.76, 
146.83, 149.62 ppm.  HRMS (ESI+): calcd for C16H25O4 – H2O: 263.1647; found: 
263.1643. 
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-4-phenyl-butan-1-ol (4g). Yield 
20%. 1H NMR (400 MHz, CDCl3): 1.60 (1H, m), 1.74 (2H, m), 1.85 (2H, m), 2.18 (2H, 
m), 2.64 (2H,t, J = 6.4 Hz), 3.83 (3H, s), 3.90 (2H, m), 4.04 (3H, s), 4.60 (1H, m), 4.95 
(1H, m), 6.83 (1H, d, J = 2 Hz), 6.84 (1H, s), 6.87-6.89 (1H, dd, J = 1.6, 1.6 Hz), 7.15 
(3H, m), 7.25 (2H, d, J = 6.8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 27.61, 33.07, 
35.72, 38.51, 56.06, 67.22, 73.02, 74.17, 78.84, 112.01, 113.49, 119.36, 125.77, 128.30, 
128.42, 137.39, 142.22, 146.92,149.73 ppm.  HRMS (ESI+): calcd for C21H27O4 – H2O: 
325.1804; found: 325.1792.  
 122
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-phenyl-propan-1-ol (4h). 
Yield 99%. 1H NMR (400 MHz, CDCl3): 1.96-2.00 (1H, m), 2.09 (1H, s), 2.11-2.18 (2H, 
m),  2.63-2.72 (2H, m), 3.83 (3H, s), 3.82 (3H, m), 3.85-3.90 (1H, m), 3.94-4.03 (3H, m), 
4.59 (1H, t, J = 7.2 Hz), 4.93-4.95 (1H, m), 6.83 (1H, s), 6.85 (1H,s), 6.91 (1H, d, J = 8.4 
Hz), 7.17 (3H, t, J = 4.4 Hz), 7.25-7.29 (2H, dd, J = 7.2, 7.6 Hz) ppm. 13C NMR (100 
MHz, CDCl3): 32.14, 33.07, 40.49, 56.07, 67.22, 73.00, 73.49, 78.86, 112.08, 113.63, 
119.41, 125.89, 128.42, 128.44, 137.35, 141.79, 146.92, 149.76 ppm.  HRMS (ESI+): 
calcd for C20H25O4 – H2O: 311.1647; found: 311.1639. Anal. Calcd for C20H24O4: C, 
73.15; H, 7.37; found: C, 73.25; H, 7.56.      
3-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-propan-1-ol (4i). 
Yield 70%. 1H NMR (400 MHz, CDCl3): 0.86 (2H, t, J = 12 Hz), 1.09-1.30 (7H, m), 
1.61-1.69 (6H, m), 1.74-1.77 (2H, m), 2.16-2.20 (2H, m), 3.84 (3H, d, J = 2.8 Hz), 3.88-
3.91 (1H, m), 4.54 (1H, d, J = 6.8 Hz), 4.96 (1H, s), 6.83-6.85 (2H, dd, J = 2.8,5.2 Hz), 
6.70 (1H, d, J = 7.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): 26.36, 26.65, 33.06, 33.35, 
33.53, 36.43, 37.64, 56.06, 67.22, 73.01, 74.67, 78.84, 112.00, 113.60, 119.37, 137.67, 
146.85, 149.66 ppm.  HRMS (ESI+): calcd for C20H31O4 – H2O: 317.2117; found: 
317.2112. Anal. calcd for C20H30O4: C, 71.82; H, 9.04; Found: C, 71.92 ; H, 9.10.      
2-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-ethanol (4j). Yield 
55%. 1H NMR (400 MHz, CDCl3): 0.94 (2H, m), 1.20 (2H, m), 1.36 (1H, m), 1.48 (1H, 
m), 1.69 (7H, m), 2.18 (2H, m), 3.84 (3H, s), 3.90 (1H, m), 4.00 (2H, m), 4.71 (1H, s), 
4.96 (1H, s), 6.83 (1H, s), 6.85 (1H, s), 6.92 – 6.89 (1H, q, J = 2.0, 6.0 Hz) ppm. 13C 
NMR (100 MHz, CDCl3): 26.17, 26.29, 26.56, 33.03, 33.07, 33.91, 34.29, 46.97, 56.07, 
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67.23, 71.79, 73.01, 78.86, 112.06, 113.59, 113.63, 119.27, 138.03, 146.88, 149.68 ppm.  
HRMS (ESI+): calcd for C19H28O4-H2O: 303.1960; found: 303.1975. 
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-methyl-butan-1-ol (4k). Yield 
34%. 1H NMR (400 MHz, CDCl3): 0.91-0.94 (6H, q, J = 4.4, 2.0 Hz), 1.24 (1H, s), 1.44-
1.49 (1H, m), 1.64-1.72 (2H, m), 1.92 (1H, bs, O-H), 2.16-2.19 (2H, m), 3.83 (3H, s), 
3.86-3.91 (1H, m), 3.97-4.02 (3H, m), 4.64-4.67 (1H, q, J = 5.6, 2.0 Hz), 4.94-4.97 (1H, 
m), 6.84 (1H, d, J = 8.4Hz), 6.86 (1H, J = 2 Hz), 6.91-6.89 (1H, dd, J =  2, 6.4 Hz) ppm. 
13C NMR (100 MHz, CDCl3): 22.34, 23.09, 24.84, 33.04, 48.28, 56.06, 67.21, 72.41, 
72.99, 78.85, 112.04, 113.62, 119.32, 137.96, 146.89, 149.68 ppm.  HRMS (ESI+): calcd 
for C16H22O3– H2O: 263.1647; found: 263.1648. 
1-(4-Methoxy-3-(tetrahydrofuran-3-yloxy)phenyl-4-methylpentan-1-ol (4l). Yield 
68%.  1H NMR (400 MHz, CDCl3): 0.85-0.88 (6H, dd, J = 2.0, 4.4 Hz), 1.08-1.14 (1H, 
m), 1.25-1.33 (1H, m), 1.51-1.57 (1H, m), 1.62-1.81 (2H, m), 1.82 (1H, b, s), 2.15-2.20 
(2H, m), 3.84 (3H, s), 3.87-3.93 (1H, m), 3.99-4.05 (3H, m), 4.56 (1H, t, J = 6.8 Hz), 
4.95-4.99 (1H, m), 6.84-6.87 (2H, m), 6.89-6.92 (1H, dd, J = 6.0, 2.0 Hz) ppm. 13C NMR 
(100 MHz, CDCl3): 22.57, 27.99, 33.05, 33.07, 34.99, 36.93, 56.06, 67.22, 73.01, 74.66 
78.85, 112.0, 113.57, 113.60, 119.37, 137.63, 146.87, 149.69 ppm. HRMS (ESI+): calcd 
for C17H26O4-H2O: 276.1801; found: 277.1797. 
1-[4-Difluoromethoxy-3-(tetrahydro-furan-3-ylxoy)-phenyl]-2,2-dimethyl-propan-1-
ol(4m).  Yield 8.6%. 1H NMR (400 MHz, CDCl3): 0.92 (9H, d, J = 0.8 Hz ), 1.95 (1H, 
s), 2.16-2.20 (2H, m), 3.90-3.92 (1H, m), 3.98-4.00 (3H, m), 4.36 (1H, s), 4.96 (1H, d, J 
= 2.0 Hz), 6.52 (1H, (d) t, J = 75.2 Hz), 6.85-6.87 (1H, dd, J = 2.0, 6.0 Hz), 6.89-6.91 
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(1H, dd, J = 2.0, 2.4 Hz), 7.11 (1H, d, J = 8.0 Hz) ppm. 13C NMR (100 MHz, CDCl3): 
25.88, 29.71, 32.98, 33.02, 35.71, 67.16, 72.80, 72.83, 78.72, 81.73, 114.69 (t, J = 160 
Hz), 120.96, 121.93, 140.05, 140.88, 148.17 ppm. MS (EI+): calcd for C16H22F2O4: 316; 
found: 316. 
3[2-Difluoromethoxy-5-91-hydroxy-3-methyl-butyl)-phenoxy]-pyrrolidine-1-
carboxylic acid tert-butyl ester (4n). Yield 14%. 1H NMR (400 MHz, CDCl3): 0.96 
(6H, d, J = 6.4 Hz), 1.46 (9H, s), 1.69 (2H, m), 1.90 (1H, d, J = 2.8 Hz), 2.20 (2H, m), 
3.57 (4H, m), 4.71 (1H, s), 4.94 (1H, s), 6.65 (1H, d(t), J = 75.2 Hz), 6.92 (1H, d, J = 6.8 
Hz), 6.97 (1H, d, J = 1.2 Hz), 7.12 (1H, d, J = 6.4 Hz) ppm. 13C NMR (100 MHz, 
CDCl3): 14.1 (d), 22.6, 24.7, 28.4, 31.5, 43.6 (d), 48.5, 51.5 (d), 60.3, 72.1, 79.60, 113.5 
(d, J = 14 Hz), 119.4, 122.9, 140.3 ppm.  HRMS (ESI+): calcd for C17H21F2NO4- (H2O + 
t-butyl) : 342.1515; found: 342.1159.  
3-[2-Difluoromethoxy-5-(1-hydroxy-pentyl)-phenoxy]-pyrrolidine-1-carboxylic acid 
tert-butyl ester (4o). Yield 25%. 1H NMR (400 MHz, CDCl3): 0.89 (3H, t, J = 6.8 Hz), 
1.36 (4H, m), 1.46 (9H, s), 1.73 (2H, m), 1.95 (1H, d, J = 2.8 Hz), 2.20 (2H, m), 3.67 
(4H, m), 4.63 (1H, s), 4.93 (1H, s), 6.65 (1H, t, J = 75.2 Hz), 6.91 (1H, s), 6.96 (1H, d, J 
= 1.6 Hz), 7.12 (1H, d, J = 6.8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 14.0, 22.55, 27.9, 
28.47, 29.72, 30.82, 31.67, 39.02, 44.07, 51.08, 51.57, 74.02, 78.11, 79.61, 113.4, 119.4, 
122.89 ppm.  HRMS (ESI+): calcd for C21H31F2NO5: 416.2248; found: 416.2247.  
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4.9.6. General Procedure for the Synthesis of 5 by Oxidization of the Alcohols with 
PCC 
To the solution of alcohol 4 (1 mmol) in dichloromethane (5 mL) was added PCC 
in portions. The resulting mixture was stirred at rt for 2 h. The solvent was removed in 
vacuo and the residue was purified by flash chromatography to afford 5. 
4-Methoxy-3-(tetrahydro-pyran-4-yloxy-phenyl]-quinolin-3-yl-methanone (5a).  
Yield 88%. 1H NMR (400 MHz, CDCl3): 1.85-1.92 (2H, m), 2.04 – 2.10 (2H, m), 3.53-
3.59 (2H, m), 3.97 (3H, s), 4.02 (2H, t, J = 6.0 Hz), 4.00-4.05 (2H, m), 4.56 (1H, m), 6.97 
(2H, d, J = 8.4 Hz), 7.45-7.47 (1H, dd, J = 2.0, 6.4 Hz), 7.58 (1H, d, J = 1.6 Hz), 7.65 
(1H, t, J = 7.2 Hz), 7.86 (1H, t, J = 6.8 Hz), 8.21 (1H, d, J = 8.4 Hz), 8.54 (1H, d, J = 2.0 
Hz), 9.27 (1H, d, J = 2.0 Hz) ppm.13C NMR (100 MHz, CDCl3): 29.72, 31.95, 56.19, 
65.34, 73.75, 110.89, 117.15, 126.71, 127.60, 129.02, 129.51, 131.65, 138.27, 146.75, 
150.27 ppm.  MS (ESI+): calcd for C22H21NO4: 363.1; found: 363. 
1-[4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-phenyl]-butan-1-one (5b). Yield 63%. 1H 
NMR (400 MHz, CDCl3): 1.02 (3H, t, J = 7.2 Hz ), 1.78 - 1.73 (2H, q, J = 7.6, 6.4 Hz), 
1.85 (2H, m), 2.05 (2H, d, J = 10.8 Hz), 2.89 (2H, t, J = 7.2 Hz), 3.55 (2H, t, J = 10 Hz), 
3.92 (3H, s), 4.02 (2H, t, J = 6.0 Hz), 4.51 (1H, s), 6.91 (1H, d, J = 8.0 Hz), 7.57 (1H, s), 
7.62 (1H, d, J = 8.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.95, 18.10, 32.00, 40.08, 
56.07, 65.41, 73.70, 110.87, 115.63, 123.46, 130.33, 146.44, 154.84, 199.14 ppm.  
HRMS (ESI+): calcd for C16H22O4: 279.1596; found: 279.1606. 
1-[4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-phenyl]-pentan-1-one (5c). Yield 75%. 
1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz ), 1.41 (2H, q, J = 7.2, 7.2 Hz), 1.72 
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(2H, q, J = 7.2, 7.2 Hz), 1.84 (2H, t, J = 4.4 Hz), 2.05 (2H, d, J = 10.0 Hz), 2.90 (2H, t, J 
= 7.2 Hz), 3.55 (2H, t, J = 9.2 Hz), 3.92 (3H, s), 4.03 (2H, d, J = 11.2 Hz), 4.52 (1H, s), 
6.91 (1H, d, J = 8.0 Hz), 7.57 (1H, s), 7.62 (1H, d, J = 8.4 Hz) ppm. 13C NMR (100 MHz, 
CDCl3): 13.95, 22.52, 26.83, 31.99, 37.86, 56.04, 65.37, 73.68, 110.87, 115.67, 123.48, 
130.27, 146.42, 154.83, 199.14 ppm.  HRMS (ESI+): calcd for C17H25O4: 293.1753; 
found: 293.1754. Anal. Calcd for C17H24O4.1/8 H2O: C, 69.24; H, 8.23; found: C, 69.27; 
H, 8.61.      
4-(2-Methoxy-5-pentanoyl-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester 
(5d). Yield 75%.1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.42 (2H, q, J = 
7.2, 7.6 Hz), 1.47 (9H, s), 1.69 -1.80 (4H, m), (1.94 (2H, m), 2.91 (2H, t, J = 7.6 Hz), 
3.29 (2H, m), 3.82 (2H, m), 3.91 (3H, s), 4.51 (1H, m), 6.92 (1H, d, J = 8.4 Hz), 7.57 
(1H, d, J = 2 Hz), 7.60 (1H, dd, J = 2, 6.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.95, 
22.52, 26.83, 28.44, 30.69, 37.88, 56.03, 74.39, 79.55, 110.91, 115.90, 123.54, 130.30, 
146.47, 154.79, 154.90, 199.15 ppm.  HRMS (ESI+): calcd for C22H33NO5: 392.2437; 
found: 392.2434.   
1-[4-Methoxy-3-(piperidin-4-yloxy)-phenyl]-pentan-1-one (5e). Yield 96%. 1H NMR 
(400 MHz, CDCl3): 0.93 (3H, t, J = 7.2 Hz ), 1.36-1.43 (2H, m), 2.15 (4H, d, J = 3.6 Hz), 
2.91 (2H, t, J = 7.6 Hz), 3.33 (2H, d, J = 12 Hz), 3.53 (2H, s), 3.91 (3H, s), 4.66 (1H, t, J 
= 3.2 Hz), 6.95 (1H, d, J = 8.4 Hz), 7.56 (1H, d, J = 2 Hz), 7.66-7.69 (1H, dd, J = 2, 6.4 
Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.82, 22.43, 26.97 (d), 37.96, 40.48, 55.91, 
70.00, 111.28, 113.98, 116.83, 117.24, 125.08, 129.99, 145.59, 155.60, 161.29 (d), 
200.65 ppm.  HRMS (ESI+): calcd for C17H26NO3: 292.1913; found: 292.1900.  
 127
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-pentan-1-one (5f). Yield 92%.1H 
NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.43 (2H, q, J = 6.8, 7.2 Hz ), 1.72 
(2H, t, J = 6.8 Hz), 2.24 (2H, m), 2.91 (2H, t, J = 6.8 Hz), 3.92 (4H, s),  4.03 (3H, s), 5.03 
(1H, s), 6.90 (1H, d, J = 7.6 Hz), 7.48 (1H, s), 7.61 (1H, d, J = 8 Hz) ppm. 13C NMR 
(100 MHz, CDCl3): 13.96, 22.54, 26.84, 33.01, 37.86, 56.07, 67.23, 72.97, 78.74, 110.72, 
113.90, 123.30, 130.22, 146.90, 154.24, 199.10 ppm.  HRMS (ESI+): calcd for C16H23O4: 
279.1596; found: 279.1598.    
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-butan-1-one (5g). Yield 64%.1H 
NMR (400 MHz, CDCl3): 1.00 (3H, t, J = 7.2 Hz), 1.75 (2H, m), 2.24 (2H, m), 2.91 (2H, 
t, J = 7.2 Hz), 3.91 (4H, s), 4.06 (3H, s), 5.02 (1H, s), 6.91 (1H, d, J = 8.4 Hz), 7.48 (1H, 
s), 7.61 (1H, d, J = 8.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.98, 18.12, 33.03 (d), 
40.08, 56.07, 67.25 (d), 72.99 (d), 78.77, 110.76 (d), 113.92, 123.31, 130.27 (d), 146.92, 
154.28 (d), 198.95 ppm.  HRMS (ESI+): calcd for C15H21O4: 265.1440; found: 265.1436. 
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-4-phenyl-butan-1-one (5h). 
Yield 80%. 1H NMR (400 MHz, CDCl3): 2.11(2H, d, J = 7.6 Hz), 2.24 (2H, d, J = 5.2 
Hz ), 2.76 (2H, t, J = 7.6 Hz), 2.96 (2H, t, J = 7.6 Hz), 3.94 (4H, s), 4.06 (3H, s), 6.92 
(1H, d, J = 8.4 Hz ), 7.26 (3H, d, J = 7.2 Hz), 7.30-7.35 (2H, q, J = 7.6, 4.8 Hz ), 7.50 
(1H, s), 7.60 (1H, d, J = 8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 26.08, 33.00, 35.27, 
37.22, 56.08, 67.24, 72.97, 78.71, 110.72, 113.77, 123.27, 125.95, 128.40, 128.54, 
130.11, 141.75, 146.90, 154.30, 198.63 ppm.  HRMS (ESI+): calcd for C21H25O4: 
341.1753; found: 341.1748.   
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-phenyl-propan-1-one (5i). 
98%.1H NMR (400 MHz, CDCl3): 2.21 (2H, s), 3.06 (2H, s), 3.25 (2H, s), 3.91 (4H, s), 
4.02 (3H, s), 5.01 (1H, s), 6.89 (1H, d, J = 7.6 Hz), 7.21-7.30 (5H, m), 7.48 (1H, s), 7.60 
(1H, d, J = 6.8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 30.42, 33.00, 39.99, 56.08, 67.24, 
72.96, 78.73, 110.74, 113.80, 123.27, 126.14, 128.45, 128.54, 129.98, 141.41, 146.93, 
154.40, 197.72 ppm.  HRMS (ESI+): calcd for C20H23O4: 327.1596; found: 327.1609. 
Anal. Calcd for C20H22O4: C, 73.60; H, 6.79; found: C, 73.57; H, 7.09.      
3-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-propan-1-one (5j). 
Yield 95%. 1H NMR (400 MHz, CDCl3): 0.88-0.97 (2H, q, J = 11.6, 10 Hz),1.31 (4H, 
m), 1.76 (7H, m), 2.20 (2H, m), 2.90 (2H, t, J = 7.6 Hz), 3.90 (4H, s), 4.02 (3H, s), 5.01 
(1H, s), 6.89 (1H, d, J = 8.4 Hz), 7.47 (1H, s), 7.60 (1H, d, J = 7.6 Hz) ppm. 13C NMR 
(100 MHz, CDCl3): 26.29, 26.58, 32.18, 33.01, 33.23, 35.69, 37.48, 56.07, 67.24, 72.98, 
78.72, 110.71, 113.89, 123.29, 130.16, 146.89, 154.22, 199.38 ppm.  HRMS (ESI+): 
calcd for C20H29O4: 333.2066; found: 333.2067. Anal. Calcd for C20H28O4: C, 72.26; H, 
8.49; found: C, 71.95; H, 8.76.      
 2-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-ethanone (5k). 
Yield 78%. 1H NMR (400 MHz, CDCl3): 1.02 (2H, m), 1.29 (3H, m), 1.76 (5H, m), 1.96 
(1H, m), 2.22 (2H, m), 2.76 (2H, d, J = 6.8 Hz), 3.91(1H, s), 4.03 (3H, s), 5.02 (1H, s), 
6.90 (1H, d, J = 8.4 Hz), 7.47 (1H, d, J = 2.0 Hz), 7.60 (1H, q, J = 2.0, 6.4 Hz) ppm. 13C 
NMR (100 MHz, CDCl3): 26.18, 26.27, 33.01, 33.50, 34.96, 45.73, 56.08, 67.24, 72.99, 
78.72, 110.68, 113.89, 123.45, 130.62, 146.88, 154.24, 198.76 ppm.  HRMS (ESI+): 
calcd for C19H26O4: 319.1909; found: 319.1911 
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-methyl-butan-1-one (5l). Yield 
93%. 1H NMR (400 MHz, CDCl3): 0.99 (6H, d, J = 6.4 Hz), 2.19-2.28 (3H, m), 2.77 
(3H, d, J = 6.8 Hz), 3.90 (4H, d, J = 4.8 Hz), 4.02 (3H, t, J = 3.6 Hz), 5.02 (1H, d, J = 
3.2 Hz), 6.89 (1H, d, J = 8.4 Hz), 7.47 (1H, d, J = 1.6 Hz), 7.57-7.59 (1H, dd, J = 2.0, 
1.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): 22.82, 25.48, 29.70, 33.00, 47.01, 56.05, 
67.23, 72.97, 78.72, 110.67, 113.87, 123.39, 130.54, 146.90, 154.24, 198.73 ppm. MS 
(EI+): calcd for C16H22O4: 278; found: 278 
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-4-methyl-pentan-1-one (5m). 
Yield 93%. 1H NMR (400 MHz, CDCl3): 0.95 (6H, d, J = 6.0 Hz), 1.59-1.64 (3H, m), 
2.19-2.25 (2H, m), 2.90 (2H, t, J = 7.6 Hz), 3.88-3.94 (4H, m), 4.02-4.06 (3H, m), 5.01-
5.03 (1H, q, J = 2.4, 2.8 Hz), 6.91 (1H, d, J = 8.4 Hz), 7.48 (1H, d, J = 1.6 Hz), 7.59-
7.62 (1H, dd, J = 6.8, 1.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): 22.46, 27.90, 29.70, 
33.00, 33.64, 36.16, 56.05, 67.22, 72.97, 78.72, 110.71, 113.88, 123.29, 130.15, 146.90, 
154.23, 199.28 ppm. MS (EI+): calcd for C17H24O4: 292; found: 292. 
1-[4-Difluoromethoxy-3-(tetrahydro-furan-3-yloxy0-phenyl]-2,2-dimethyl-propan-1-
one (5n). Yield 81%. 1H NMR (400 MHz, CDCl3): 1.36 (9H, s), 2.19-2.25 (2H, m), 3.91-
3.95 (1H, m), 3.99-4.03 (3H, m), 5.00 (1H, s), 6.59 (1H, t, J = 74.8 Hz), 7.18 (1H, d, J = 
8.4 Hz), 7.30 (1H, d, J = 2.0 Hz), 7.40-7.42 (1H, dd, J = 2.0, 1.6 Hz) ppm. 13C NMR 
(100 MHz, CDCl3): 28.15, 29.71, 32.96, 44.22, 67.16, 72.81, 78.94, 115.84 (d, J = 36 
Hz), 121.77 (d), 136.04, 148.72, 206.85 ppm. MS (EI+): calcd for C16H20F2O4: 314; 
found: 314 
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3-(2-Difluoromethoxy-5-pentanoyl-phenoxy)-pyrrolidine-1-carboxylic acid tert-butyl 
ester (5o). Yield 96%.  1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.46 (9H, 
s), 1.58-1.71 (3H, m), 2.20 (3H, m), 2.90 (2H, s), 3.54-3.62 (4H, m), 5.01 (1H, s), 6.62 
(1H, t, J = 74.4 Hz), 7.23 (1H, s), 7.56 (2H, s) ppm. 13C NMR (100 MHz, CDCl3): 14.00, 
22.55, 27.90, 28.47, 30.82 (t), 39.02, 44.07(d), 51.57(d), 74.02, 78.11, 79.61, 113.87 (d, J 
= 272 Hz), 119.40, 122.89, 130.54, 146.90, 154.24, 198.73 ppm. HRMS (ESI+): calcd for 
C16H21F2NO3 – (t-butyl): 314.1567; found: 314.1758 
 
1-[3-(1-Acetyl-pyrrolidin-3-yloxy)-4-difluoromethoxy-phenyl]-3-methyl-butan-1-one 
(5q). Yield 46%. 1H NMR (400 MHz, CDCl3): 0.99 (6H, d, J = 5.2 Hz), 2.10 (3H, s), 
2.19 (1H, s), 2.26 (2H, s), 2.79 (2H, s), 3.60-3.88 (4H, m), 5.01 (1H, s), 6.53 (1H, (d)t, J 
= 74.0 Hz), 7.22 (1H, d, J = 8.4 Hz), 7.57 (2H, d, J = 8.0 Hz) ppm. 13C NMR (100 MHz, 
CDCl3): 22.19 (d), 22.65, 25.22, 30.33 (t), 45.32 (t), 52.80 (d), 78.50, 89.64, 100.83, 
115.87 (d, J = 272 Hz), 121.98 (d), 122.82 (d), 135.85, 171.15, 198.29 ppm. MS-EI: 
calcd for C18H23F2NO4: 355; found: 356 
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